<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">67450</article-id><article-id pub-id-type="doi">10.7554/eLife.67450</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Evolutionary Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group></article-categories><title-group><article-title>Glycan-based shaping of the microbiota during primate evolution</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-226852"><name><surname>Singh</surname><given-names>Sumnima</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-1826-0180</contrib-id><xref ref-type="aff" rid="aff1"/><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/><xref ref-type="fn" rid="pa1">‡</xref></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-226853"><name><surname>Bastos-Amador</surname><given-names>Patricia</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/><xref ref-type="fn" rid="pa2">§</xref></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-226854"><name><surname>Thompson</surname><given-names>Jessica Ann</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-226902"><name><surname>Truglio</surname><given-names>Mauro</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-226903"><name><surname>Yilmaz</surname><given-names>Bahtiyar</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/><xref ref-type="fn" rid="pa3">#</xref></contrib><contrib contrib-type="author" id="author-226904"><name><surname>Cardoso</surname><given-names>Silvia</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-179510"><name><surname>Sobral</surname><given-names>Daniel</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-3955-0117</contrib-id><xref ref-type="aff" rid="aff1"/><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/><xref ref-type="fn" rid="pa4">¶</xref></contrib><contrib contrib-type="author" corresp="yes" id="author-191771"><name><surname>Soares</surname><given-names>Miguel P</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-9314-4833</contrib-id><email>mpsoares@igc.gulbenkian.pt</email><xref ref-type="aff" rid="aff1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund6"/><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution>Instituto Gulbenkian de Ciência</institution><addr-line><named-content content-type="city">Oeiras</named-content></addr-line><country>Portugal</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Turnbaugh</surname><given-names>Peter</given-names></name><role>Reviewing Editor</role><aff><institution>University of California, San Francisco</institution><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Perry</surname><given-names>George H</given-names></name><role>Senior Editor</role><aff><institution>Pennsylvania State University</institution><country>United States</country></aff></contrib></contrib-group><author-notes><fn fn-type="present-address" id="pa1"><label>‡</label><p>Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, United States</p></fn><fn fn-type="present-address" id="pa2"><label>§</label><p>Champalimaud Centre for the Unknown, Lisbon, Portugal</p></fn><fn fn-type="present-address" id="pa3"><label>#</label><p>Department for Biomedical Research, Inselspital, University of Bern, Bern, Switzerland</p></fn><fn fn-type="present-address" id="pa4"><label>¶</label><p>Universidade Nova de Lisboa, Caparica, Portugal</p></fn><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date date-type="publication" publication-format="electronic"><day>19</day><month>05</month><year>2021</year></pub-date><pub-date pub-type="collection"><year>2021</year></pub-date><volume>10</volume><elocation-id>e67450</elocation-id><history><date date-type="received" iso-8601-date="2021-02-11"><day>11</day><month>02</month><year>2021</year></date><date date-type="accepted" iso-8601-date="2021-05-04"><day>04</day><month>05</month><year>2021</year></date></history><permissions><copyright-statement>© 2021, Singh et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Singh et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-67450-v1.pdf"/><abstract><p>Genes encoding glycosyltransferases can be under relatively high selection pressure, likely due to the involvement of the glycans synthesized in host-microbe interactions. Here, we used mice as an experimental model system to investigate whether loss of α−1,3-galactosyltransferase gene (<italic>GGTA1</italic>) function and Galα1-3Galβ1-4GlcNAcβ1-R (αGal) glycan expression affects host-microbiota interactions, as might have occurred during primate evolution. We found that <italic>Ggta1</italic> deletion shaped the composition of the gut microbiota. This occurred via an immunoglobulin (Ig)-dependent mechanism, associated with targeting of αGal-expressing bacteria by IgA. Systemic infection with an Ig-shaped microbiota inoculum elicited a less severe form of sepsis compared to infection with non-Ig-shaped microbiota. This suggests that in the absence of host αGal, antibodies can shape the microbiota towards lower pathogenicity. Given the fitness cost imposed by bacterial sepsis, we infer that the observed reduction in microbiota pathogenicity upon <italic>Ggta1</italic> deletion in mice may have contributed to increase the frequency of <italic>GGTA1</italic> loss-of-function mutations in ancestral primates that gave rise to humans.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>immunology</kwd><kwd>Alpha-gal</kwd><kwd>primate evolution</kwd><kwd>microbiota</kwd><kwd>sepsis</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001871</institution-id><institution>Fundação para a Ciência e a Tecnologia</institution></institution-wrap></funding-source><award-id>SFRH/BD/52177/2013</award-id><principal-award-recipient><name><surname>Singh</surname><given-names>Sumnima</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001871</institution-id><institution>Fundação para a Ciência e a Tecnologia</institution></institution-wrap></funding-source><award-id>SFRH/BPD/112135/2015</award-id><principal-award-recipient><name><surname>Soares</surname><given-names>Miguel</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001704</institution-id><institution>European Society of Clinical Microbiology and Infectious Diseases</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Thompson</surname><given-names>Jessica Ann</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100005635</institution-id><institution>Fundação Calouste Gulbenkian</institution></institution-wrap></funding-source><award-id>5723/2014 and FEDER029411</award-id><principal-award-recipient><name><surname>Soares</surname><given-names>Miguel</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000865</institution-id><institution>Bill and Melinda Gates Foundation</institution></institution-wrap></funding-source><award-id>OPP1148170</award-id><principal-award-recipient><name><surname>Soares</surname><given-names>Miguel</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010434</institution-id><institution>“la Caixa” Foundation</institution></institution-wrap></funding-source><award-id>HR18-00502</award-id><principal-award-recipient><name><surname>Soares</surname><given-names>Miguel</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value><italic>Ggta1</italic> deletion in mice shapes and reduces the microbiota pathogenicity and probably contributed to the natural selection of <italic>GGTA1</italic> loss-of-function mutations in the ancestral primates that gave rise to humans.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>As originally proposed by J.B.S. Haldane, infectious diseases are a major driving force of natural selection (<xref ref-type="bibr" rid="bib30">Haldane, 1949</xref>), occasionally precipitating ‘catastrophic-selection’ events: the replacement of an entire, susceptible, parental population by mutant offspring that are resistant to a given infectious disease (<xref ref-type="bibr" rid="bib39">Lewis, 1962</xref>). Such an event is proposed to have occurred during primate evolution between 20–30 million‐years‐ago, possibly due to the selective pressure exerted by an airborne, enveloped virus carrying Galα1-3Galβ1-4GlcNAc (αGal)-like glycans (<xref ref-type="bibr" rid="bib21">Galili, 2016</xref>; <xref ref-type="bibr" rid="bib22">Galili, 2019</xref>). If proven correct, this would contribute to the evolutionary pressure that led to the selection and fixation of <italic>GGTA1</italic> loss-of-function mutations in ancestral primates (<xref ref-type="bibr" rid="bib20">Galili et al., 1988</xref>).</p><p>Loss of the α1,3-galactosyltransferase enzyme, encoded by <italic>GGTA1</italic>, eliminated the expression of protein-bound αGal, allowing for immune targeting of this non-self glycan (<xref ref-type="bibr" rid="bib19">Galili et al., 1987</xref>). This increased resistance to infection by αGal-expressing pathogens (<xref ref-type="bibr" rid="bib56">Repik et al., 1994</xref>; <xref ref-type="bibr" rid="bib67">Takeuchi et al., 1996</xref>), including parasites of the <italic>Plasmodium</italic> spp. (<xref ref-type="bibr" rid="bib61">Soares and Yilmaz, 2016</xref>; <xref ref-type="bibr" rid="bib73">Yilmaz et al., 2014</xref>), which exerted a major impact on human evolution (<xref ref-type="bibr" rid="bib1">Allison, 1954</xref>).</p><p>We recently uncovered a possible fitness advantage associated with loss of <italic>GGTA1</italic> function, which acts independently of αGal-specific immunity (<xref ref-type="bibr" rid="bib60">Singh et al., 2021</xref>). Namely, loss of αGal from immunoglobulin (Ig)G-associated glycan structures increased IgG effector function and resistance to bacterial sepsis in mice (<xref ref-type="bibr" rid="bib60">Singh et al., 2021</xref>).</p><p>Sepsis is a life-threatening organ dysfunction caused by a deregulated response to infection (<xref ref-type="bibr" rid="bib59">Singer et al., 2016</xref>) that accounts for 20% of global human mortality (<xref ref-type="bibr" rid="bib57">Rudd et al., 2020</xref>). The pathogenesis of sepsis is modulated by stable host symbiotic associations with microbial communities composed of bacteria, fungi, and viruses, known as the microbiota (<xref ref-type="bibr" rid="bib57">Rudd et al., 2020</xref>; <xref ref-type="bibr" rid="bib70">Vincent et al., 2009</xref>). While host-microbiota interactions provide a broad range of fitness advantages to the host (<xref ref-type="bibr" rid="bib38">Lane-Petter, 1962</xref>; <xref ref-type="bibr" rid="bib71">Vonaesch et al., 2018</xref>), these also carry fitness costs, for example, when bacterial pathobionts (<xref ref-type="bibr" rid="bib12">Chow et al., 2011</xref>) translocate across host epithelial barriers to elicit the development of sepsis (<xref ref-type="bibr" rid="bib57">Rudd et al., 2020</xref>; <xref ref-type="bibr" rid="bib70">Vincent et al., 2009</xref>). On the basis of this evolutionary trade-off (<xref ref-type="bibr" rid="bib65">Stearns and Medzhitov, 2015</xref>), it has been argued that the immune system may have emerged, in part, to mitigate the pathogenic effects of the microbiota (<xref ref-type="bibr" rid="bib32">Hooper et al., 2012</xref>; <xref ref-type="bibr" rid="bib45">McFall-Ngai, 2007</xref>). Central to this host defence strategy is the transepithelial secretion of copious amounts of IgA natural antibodies (NAb), which target immunogenic bacteria in the microbiota (<xref ref-type="bibr" rid="bib42">Macpherson et al., 2000</xref>).</p><p>IgA recognize a broad but defined subset of immunogenic bacteria in the gut microbiota (<xref ref-type="bibr" rid="bib7">Bunker et al., 2017</xref>; <xref ref-type="bibr" rid="bib6">Bunker et al., 2015</xref>; <xref ref-type="bibr" rid="bib42">Macpherson et al., 2000</xref>), exerting negative or positive selection pressure on these bacteria, shaping the microbiota composition, ecology, and potentially its pathogenicity (<xref ref-type="bibr" rid="bib37">Kubinak and Round, 2016</xref>). Negative selection can occur, for example, when IgA limits bacterial growth (<xref ref-type="bibr" rid="bib50">Moor et al., 2017</xref>), while positive selection can occur, for example, when IgA promotes bacterial interactions with the host, favoring bacterial retention, fitness, and colonization (<xref ref-type="bibr" rid="bib17">Donaldson et al., 2018</xref>; <xref ref-type="bibr" rid="bib46">McLoughlin et al., 2016</xref>). Moreover, IgA can interfere with cognate interactions between bacteria and tissue resident immune cells at epithelial barriers, regulating microbiota-specific immune responses, including the production of circulating IgM and IgG NAb (<xref ref-type="bibr" rid="bib34">Kamada et al., 2015</xref>; <xref ref-type="bibr" rid="bib74">Zeng et al., 2016</xref>).</p><p>Here, we provide experimental evidence in mice to suggest that the fixation of <italic>GGTA1</italic> loss-of-function mutations during primate evolution exerted a major impact on the composition of their gut microbiota. In support of this notion, mice in which <italic>Ggta1</italic> is disrupted (<italic>Ggta1<sup>-/-</sup></italic>), mimicking human <italic>GGTA1</italic> loss-of-function mutations, modulated their gut microbiota composition. This occurs predominantly via an Ig-dependent mechanism, associated with an enhancement of the production of IgA, targeting αGal-expressing bacteria in the gut microbiota. The pathogenicity of the Ig-shaped microbiota is reduced, failing to elicit lethal forms of sepsis upon systemic infection. We propose that <italic>GGTA1</italic> loss-of-function mutations conferred a selective benefit during primate evolution, in part, by shaping commensal bacteria in the microbiota to mitigate the pathogenesis of sepsis.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title><italic>Ggta1</italic> deletion shapes the microbiota composition</title><p>We have previously established that <italic>Ggta1<sup>-/-</sup></italic> mice harbor a distinct microbiota composition to that of wild type (<italic>Ggta1<sup>+/+</sup></italic>) mice (<xref ref-type="bibr" rid="bib60">Singh et al., 2021</xref>). This is illustrated by the relative abundance of specific bacterial taxa, such as an increase in Proteobacteria, Tenericutes, and Verrucomicrobia as well as a reduction in Bacterioidetes and Deferribacteres phyla in <italic>Ggta1<sup>-/-</sup></italic> mice compared to <italic>Ggta1<sup>+/+</sup></italic> mice (<xref ref-type="fig" rid="fig1">Figure 1A</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplements 1</xref> and <xref ref-type="fig" rid="fig1s2">2</xref>; <xref ref-type="bibr" rid="bib60">Singh et al., 2021</xref>). The relative increase of Proteobacteria, a phylum containing several strains associated with pathogenic behavior, in the gut microbiota of <italic>Ggta1<sup>-/-</sup></italic> mice was not, however, associated with the development of histological lesions in the gastrointestinal tract (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3A</xref>). Absence of intestinal inflammation was further assessed by quantification of fecal lipocalin-2 (Lcn-2) (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3B</xref>; <xref ref-type="bibr" rid="bib10">Chassaing et al., 2012</xref>). There were also no histopathological lesions in the liver, lungs, kidney, and spleen (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3C</xref>), suggesting that <italic>Ggta1<sup>-/-</sup></italic> mice maintain symbiotic interactions with these pathobionts, without compromising organismal homeostasis.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title><italic>Ggta1</italic> deletion alters the gut microbiota.</title><p>(<bold>A</bold>) Linear discriminant analysis (LDA) scores generated from LEfSe analysis, representing taxa enriched in the fecal microbiota of <italic>Ggta1<sup>+/+</sup></italic> (green) (n = 15) and <italic>Ggta1<sup>-/-</sup></italic> (red) (n = 14) mice. (<bold>B</bold>) Breeding strategy where F<sub>0 </sub><italic>Ggta1<sup>-/-</sup></italic> males were crossed with <italic>Ggta1<sup>+/+</sup></italic> females to generate F<sub>1</sub> <italic>Ggta1<sup>+/-</sup></italic> mice, which were bred to generate F<sub>2</sub> <italic>Ggta1<sup>+/+</sup> vs. Ggta1<sup>-/-</sup></italic> littermates. These were subsequently bred to generate F<sub>3</sub> to F<sub>5</sub> <italic>Ggta1<sup>+/+</sup> vs. Ggta1<sup>-/-</sup></italic> mice. Microbiota Principal Coordinate Analysis of Unweighted Unifrac distance in fecal samples from (<bold>C</bold>) F<sub>0 </sub><italic>Ggta1<sup>+/+</sup></italic> (n = 15), F<sub>1 </sub><italic>Ggta1<sup>+/-</sup></italic> (n = 15), F<sub>2 </sub><italic>Ggta1<sup>+/+</sup></italic> (n = 11) and F<sub>2 </sub><italic>Ggta1<sup>-/-</sup></italic> (n = 10) mice, (<bold>D</bold>) F<sub>3 </sub><italic>Ggta1<sup>+/+</sup></italic> (n = 9) and <italic>Ggta1<sup>-/-</sup></italic> (n = 8) mice, (<bold>E</bold>) F<sub>4</sub> <italic>Ggta1<sup>+/+</sup></italic> (n = 13) and <italic>Ggta1<sup>-/-</sup></italic> (n = 7) mice and (<bold>F</bold>) F<sub>5</sub> <italic>Ggta1<sup>+/+</sup></italic> (n = 7) and <italic>Ggta1<sup>-/-</sup></italic> (n = 12) mice generated as in (<bold>B</bold>). Data from one experiment with two to three independent breedings/cages per genotype. Symbols (<bold>C–F</bold>) are individual mice. p Values (<bold>C–F</bold>) calculated using PERMANOVA test.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-67450-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Analyses of gut microbiota composition of <italic>Ggta1<sup>+/+</sup></italic> and <italic>Ggta1<sup>-/-</sup></italic> mice.</title><p>Relative abundance of bacteria at all levels of taxonomy, present at &gt;2% frequency, in the same mice as in <xref ref-type="fig" rid="fig1">Figure 1A</xref>. Symbols represent individual mice. Red bars correspond to mean values. Error bars correspond to SD. Adjusted p values calculated using Benjamini-Hochberg correction. *p&lt;0.05, **p&lt;0.01, ***p&lt;0.005, ****p&lt;0.001.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-67450-fig1-figsupp1-v1.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 2.</label><caption><title>Analyses of gut microbiota composition of <italic>Ggta1<sup>+/+</sup> vs</italic>. <italic>Ggta1<sup>-/-</sup></italic> mice.</title><p>Relative abundance of bacteria at all levels of taxonomy, present at &gt;2% frequency in the same mice as in <xref ref-type="fig" rid="fig1">Figure 1A</xref>. Stacked bars represent the mean of the bacterial taxa. Colors represent the relative fraction of each taxon. Data from one experiment.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-67450-fig1-figsupp2-v1.tif"/></fig><fig id="fig1s3" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 3.</label><caption><title><italic>Ggta1</italic> deletion does not cause inflammation at steady state.</title><p>(<bold>A</bold>) Representative H/E sections of the small intestine, large intestine, liver, spleen, lung and kidney of <italic>Ggta1<sup>+/+</sup></italic> (n = 5) and <italic>Ggta1<sup>-/-</sup></italic> (n = 5) mice at steady state. (<bold>B</bold>) Fecal Lcn-2 concentrations in <italic>Ggta1<sup>+/+</sup></italic> (n = 10) and <italic>Ggta1<sup>-/-</sup></italic> (n = 10) mice at steady state. Symbols represent individual mice. Red bars correspond to mean values. Error bars correspond to SD, ns: not significant.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-67450-fig1-figsupp3-v1.tif"/></fig><fig id="fig1s4" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 4.</label><caption><title><italic>Ggta1</italic> deletion shapes the gut microbiota composition.</title><p>Relative abundance of bacteria at all levels of taxonomy, present at &gt;2% frequency in the same mice as in <xref ref-type="fig" rid="fig1">Figure 1C–F</xref>. Stacked bars represent the mean of the bacterial taxa. Colors represent the relative fraction of each taxon. Data from one experiment.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-67450-fig1-figsupp4-v1.tif"/></fig></fig-group><p>To establish whether the differences in the bacterial species present in the gut microbiota of <italic>Ggta1<sup>-/-</sup> vs. Ggta1<sup>+/+</sup></italic> mice are propelled by host genetics, we used an experimental system whereby the microbiota is vertically transmitted over several generations (<xref ref-type="bibr" rid="bib69">Ubeda et al., 2012</xref>) from <italic>Ggta1<sup>+/+</sup></italic> mice to <italic>Ggta1<sup>-/-</sup></italic> and <italic>Ggta1<sup>+/+</sup></italic> offspring (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). This approach enables effects exerted by the host genotype on microbiota composition to predominate over those exerted by environmental factors (<xref ref-type="bibr" rid="bib23">Gálvez et al., 2017</xref>; <xref ref-type="bibr" rid="bib71">Vonaesch et al., 2018</xref>), diet (<xref ref-type="bibr" rid="bib62">Sonnenburg et al., 2016</xref>), cohousing or familial transmission (<xref ref-type="bibr" rid="bib69">Ubeda et al., 2012</xref>), albeit not accounting for putative cage effects or genetic drift (<xref ref-type="bibr" rid="bib63">Spor et al., 2011</xref>).</p><p>The microbiota composition of F<sub>1</sub> <italic>Ggta1<sup>+/-</sup></italic> well as F<sub>2</sub> <italic>Ggta1<sup>+/+</sup></italic> and <italic>Ggta1<sup>-/-</sup></italic> mice diverged from that of the original F<sub>0</sub> <italic>Ggta1<sup>+/+</sup></italic> mice (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). While indistinguishable in F<sub>2</sub> <italic>Ggta1<sup>+/+</sup></italic> and <italic>Ggta1<sup>-/-</sup></italic> littermates (<xref ref-type="fig" rid="fig1">Figure 1C</xref>; <xref ref-type="bibr" rid="bib60">Singh et al., 2021</xref>), the microbiota composition diverged between <italic>Ggta1<sup>+/+</sup></italic> and <italic>Ggta1<sup>-/-</sup></italic> mice in F<sub>3</sub> (<xref ref-type="fig" rid="fig1">Figure 1D</xref>), F<sub>4</sub> (<xref ref-type="fig" rid="fig1">Figure 1E</xref>) and F<sub>5</sub> (<xref ref-type="fig" rid="fig1">Figure 1F</xref>) generations, suggesting that the <italic>Ggta1</italic> genotype per se alters microbiota composition. There was an enrichment of some bacterial taxa, such as Helicobactereaceae, in the microbiota of F<sub>2</sub> to F<sub>5 </sub><italic>Ggta1<sup>-/-</sup></italic> and <italic>Ggta1<sup>+/+</sup></italic> mice (<xref ref-type="fig" rid="fig1s4">Figure 1—figure supplement 4</xref>), despite the absence of these bacteria in the original F<sub>0</sub> <italic>Ggta1<sup>+/+</sup></italic> microbiota (<xref ref-type="fig" rid="fig1s4">Figure 1—figure supplement 4</xref>). This suggests that the <italic>Ggta1</italic> genotype shapes the gut microbiota composition via a process that is probably influenced by colonization by environmental pathobionts (<xref ref-type="bibr" rid="bib23">Gálvez et al., 2017</xref>).</p></sec><sec id="s2-2"><title><italic>Ggta1</italic> deletion enhances IgA responses to the gut microbiota</title><p>Considering that IgA shapes the bacterial species present in the microbiota (<xref ref-type="bibr" rid="bib6">Bunker et al., 2015</xref>; <xref ref-type="bibr" rid="bib43">Macpherson et al., 2018</xref>; <xref ref-type="bibr" rid="bib53">Peterson et al., 2007</xref>), we asked whether differences in IgA responses could contribute to shape the microbiota of <italic>Ggta1<sup>-/-</sup> vs. Ggta1<sup>+/+</sup></italic> mice. In keeping with this notion, the relative levels of microbiota-reactive circulating IgA were higher in <italic>Ggta1<sup>-/-</sup> vs. Ggta1<sup>+/+</sup></italic> mice, maintained under specific pathogen-free (SPF) but not germ-free (GF) conditions (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). Under SPF conditions, <italic>Ggta1<sup>-/-</sup></italic> mice had similar levels of secreted (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>) and circulating (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref>) total IgA, compared to <italic>Ggta1<sup>+/+</sup></italic> mice. These were reduced to a similar extent under GF conditions (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A and B</xref>), suggesting that <italic>Ggta1</italic> deletion enhances microbiota-specific IgA responses without interfering with total IgA.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title><italic>Ggta1</italic> deletion enhances IgA responses to the gut microbiota.</title><p>(<bold>A</bold>) Relative binding of IgA in the serum of <italic>Ggta1<sup>+/+</sup></italic> (n = 10) and GF <italic>Ggta1<sup>+/+</sup></italic> (n = 5) mice to fecal extract from <italic>Ggta1<sup>+/+</sup></italic> mice, and <italic>Ggta1<sup>-/-</sup></italic> (n = 6) and GF <italic>Ggta1<sup>-/-</sup></italic> (n = 6) mice to fecal extract from <italic>Ggta1<sup>-/-</sup></italic> mice; one experiment. (<bold>B</bold>) Relative binding of IgA in the serum of GF <italic>Ggta1<sup>+/+</sup></italic> (n = 7) and GF <italic>Ggta1<sup>-/-</sup></italic> (n = 10) mice to cecal extract from <italic>Ggta1<sup>-/-</sup></italic> mice at indicated time-points after colonization with cecal extract from <italic>Ggta1<sup>-/-</sup></italic> mice; two experiments. (<bold>C</bold>) Median Fluorescence Intensity (MFI) of αGal<sup>+</sup> bacterial strains stained with BSI-B4 lectin relative to unstained control; seven experiments. (<bold>D</bold>) Representative flow cytometry plots showing bacteria stained for IgA and αGal in the small intestinal content of <italic>Ggta1<sup>+/+</sup></italic> (n = 5) and <italic>Ggta1<sup>-/-</sup></italic> (n = 11) mice; four independent experiments. (<bold>E</bold>) Quantification of αGal<sup>+</sup>, IgA<sup>+</sup>, and IgA<sup>+</sup>αGal<sup>+</sup> bacteria in the same samples as in (<bold>D</bold>). (<bold>F</bold>) Concentration of anti-αGal IgM in serum of <italic>Ggta1<sup>+/+</sup></italic> (n = 2), <italic>Ggta1<sup>-/-</sup></italic> (n = 12), <italic>Igha<sup>-/-</sup>Ggta1<sup>+/+</sup></italic> (n = 10), and <italic>Igha<sup>-/-</sup>Ggta1<sup>-/-</sup></italic> (n = 12) mice before and after streptomycin treatment, two experiments. (<bold>G</bold>) Concentration of anti-αGal IgG, in the same mice as (<bold>F</bold>). Symbols (<bold>A, B, E, F, G</bold>) are individual mice. Red bars (<bold>A, B, E, F, G</bold>) correspond to mean values. Error bars (<bold>A, B, C, E, F, G</bold>) correspond to SD. p Values in (<bold>A, B, F, G</bold>) calculated using Kruskal-Wallis test using Dunn’s multiple comparisons test and in (<bold>E</bold>) using Mann-Whitney test. *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, ****p&lt;0.0001, ns: not significant.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-67450-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title><italic>Ggta1</italic> deletion enhances IgA responses to the gut microbiota.</title><p>(<bold>A</bold>) Concentration of total IgA in serum of <italic>Ggta1<sup>+/+</sup></italic> (n = 9), GF <italic>Ggta1<sup>+/+</sup></italic> (n = 5), <italic>Ggta1<sup>-/-</sup></italic> (n = 5) and GF <italic>Ggta1<sup>-/-</sup></italic> (n = 6) mice. (<bold>B</bold>) Concentration of total IgA in the small intestinal content of <italic>Ggta1<sup>+/+</sup></italic> (n = 10), GF <italic>Ggta1<sup>+/+</sup></italic> (n = 5), <italic>Ggta1<sup>-/-</sup></italic> (n = 10) and GF <italic>Ggta1<sup>-/-</sup></italic> (n = 5) mice. (<bold>C</bold>) Relative binding of IgA in the serum of GF <italic>Ggta1<sup>+/+</sup></italic> (n = 5) and GF <italic>Ggta1<sup>-/-</sup></italic> (n = 5) mice to fecal extract from <italic>Ggta1<sup>+/+</sup></italic> mice at indicated time-points after colonization with cecal extract from <italic>Ggta1<sup>+/+</sup></italic> mice; two experiments. (<bold>D</bold>) Concentration of total IgA in serum of <italic>Ggta1<sup>-/-</sup></italic> (n = 7), <italic>Tcrb<sup>-/-</sup>Ggta1<sup>-/-</sup></italic> (n = 12) mice. (<bold>E</bold>) Representative plots showing the gating strategy for staining of intestinal content with Syto41, BSI-B4, and Anti-IgA. (<bold>F</bold>) Quantification of αGal<sup>+</sup>, IgA<sup>+</sup>, and IgA<sup>+</sup>αGal<sup>+</sup> bacteria in the cecum, colon, and feces of the same mice as in <xref ref-type="fig" rid="fig2">Figure 2D–E</xref>. Symbols (<bold>A, B, C, D, F</bold>) are individual mice. Red bars (<bold>A, B, C, D, F</bold>) correspond to mean values. Error bars (<bold>A, B, C, D, F</bold>) correspond to SD. P values in (<bold>A, B, C</bold>) calculated using Kruskal-Wallis test using Dunn’s multiple comparisons test and in (<bold>D, F</bold>) using Mann-Whitney test. *p&lt;0.05, **p&lt;0.01, ns: not significant.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-67450-fig2-figsupp1-v1.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>αGal expression by probiotic bacteria.</title><p>Representative flow cytometry plots of the data in <xref ref-type="fig" rid="fig2">Figure 2C</xref> showing probiotic bacterial strains unstained or stained with BSI-B4 lectin.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-67450-fig2-figsupp2-v1.tif"/></fig></fig-group><p>In further support of the notion that <italic>Ggta1</italic> deletion modulates the production of microbiota-specific IgA, colonization of GF <italic>Ggta1<sup>-/-</sup></italic> mice with the microbiota from <italic>Ggta1<sup>-/-</sup></italic> mice elicited the production of higher levels of microbiota-reactive circulating IgA, compared to GF <italic>Ggta1<sup>+/+</sup></italic> mice colonized by the same microbiota (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). This difference was not observed upon colonization of GF <italic>Ggta1<sup>-/-</sup> vs. Ggta1<sup>+/+</sup></italic> mice by a microbiota isolated from <italic>Ggta1<sup>+/+</sup></italic> mice (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C</xref>). This suggests that the enhanced microbiota-reactive IgA response of <italic>Ggta1<sup>-/-</sup> vs. Ggta1<sup>+/+</sup></italic> mice is induced by immunogenic bacteria present specifically in the microbiota of <italic>Ggta1<sup>-/-</sup></italic> mice.</p><p>Of note, the levels of circulating IgA were reduced in <italic>Tcrb<sup>-/-</sup>Ggta1<sup>-/-</sup></italic> mice lacking α/β T cells, when compared to <italic>Ggta1<sup>-/-</sup></italic> mice (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1D</xref>), suggesting that the production of circulating IgA NAb in <italic>Ggta1<sup>-/-</sup></italic> mice occurs, in part, via a T-cell-dependent mechanism, which is consistent with previous reports in <italic>Ggta1<sup>+/+</sup></italic> mice (<xref ref-type="bibr" rid="bib7">Bunker et al., 2017</xref>; <xref ref-type="bibr" rid="bib18">Fagarasan et al., 2010</xref>; <xref ref-type="bibr" rid="bib42">Macpherson et al., 2000</xref>).</p><p>We then asked whether <italic>Ggta1<sup>-/-</sup></italic> mice shape their microbiota via a mechanism associated with immune targeting of αGal-expressing bacteria. Consistent with a number of bacteria in the human gut microbiota carrying genes orthologous to the mammalian α1,3-galactosyltransferase (<xref ref-type="bibr" rid="bib49">Montassier et al., 2019</xref>), several human probiotic bacteria expressed αGal-like glycans at the cell surface when cultured in vitro (<xref ref-type="fig" rid="fig2">Figure 2C</xref>, <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>). Subsequent in vivo analyses demonstrated that approximately 20% of the bacteria in the small intestine of <italic>Ggta1<sup>+/+</sup></italic> mice expressed αGal-like glycans at the cell surface (<xref ref-type="fig" rid="fig2">Figure 2D,E</xref>, <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>). Nearly 30% of these αGal<sup>+</sup> bacteria were immunogenic (<xref ref-type="fig" rid="fig2">Figure 2D,E</xref>), as defined by the detection of surface-bound IgA (<xref ref-type="bibr" rid="bib52">Palm et al., 2014</xref>), which predominantly targets bacteria in the small intestine (<xref ref-type="bibr" rid="bib7">Bunker et al., 2017</xref>; <xref ref-type="bibr" rid="bib6">Bunker et al., 2015</xref>). These IgA<sup>+</sup>αGal<sup>+</sup> bacteria accounted for roughly 50% of all the immunogenic (IgA<sup>+</sup>) bacteria in the small intestine (<xref ref-type="fig" rid="fig2">Figure 2D,E</xref>). These were also present, although at a lower extent, in the cecum, colon, and feces (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1E and F</xref>).</p><p><italic>Ggta1<sup>-/-</sup></italic> mice harbored a relatively lower percentage of immunogenic IgA<sup>+</sup>αGal<sup>+</sup> bacteria in the small intestine, when compared to <italic>Ggta1<sup>+/+</sup></italic> mice (<xref ref-type="fig" rid="fig2">Figure 2D,E</xref>), while the percentage of immunogenic IgA<sup>+</sup> bacteria was similar in <italic>Ggta1<sup>-/-</sup> vs. Ggta1<sup>+/+</sup></italic> mice (<xref ref-type="fig" rid="fig2">Figure 2D,E</xref>). This is consistent with the idea of a specific mechanism altering the microbiota of <italic>Ggta1<sup>-/-</sup></italic> mice that presumably, at least in part, involves targeting immunogenic αGal<sup>+</sup> bacteria by IgA. Whether this mechanism involves the recognition of bacterial αGal-like glycans by IgA is not clear.</p><p>We then compared the effect of IgA on the levels of systemic IgM and/or IgG NAb directed against antigens expressed by bacteria present in the microbiota (<xref ref-type="bibr" rid="bib34">Kamada et al., 2015</xref>; <xref ref-type="bibr" rid="bib74">Zeng et al., 2016</xref>). Induction of dysbiosis, by streptomycin, increased the levels of circulating αGal-specific IgM and IgG in <italic>Igha</italic><sup>-/-</sup><italic>Ggta1<sup>-/-</sup> vs. Igha</italic><sup>+/+</sup><italic>Ggta1<sup>-/-</sup></italic> mice (<xref ref-type="fig" rid="fig2">Figure 2F,G</xref>). This illustrates again that the IgA response of <italic>Ggta1<sup>-/-</sup></italic> mice is distinct from that of <italic>Ggta1<sup>+/+</sup></italic> mice, reducing systemic IgM and IgG responses against antigens expressed by bacteria in the microbiota, as illustrated for αGal-like glycans. Presumably this occurs via a mechanism whereby IgA prevents αGal<sup>+</sup> bacteria or bacterial products associated to αGal from translocating across epithelial barriers and inducing systemic immune responses against this glycan.</p></sec><sec id="s2-3"><title><italic>Ggta1</italic> deletion shapes the gut microbiota via an antibody (Ig)-dependent mechanism</title><p>Maintenance of microbiota composition across generations is sustained via maternal IgG transfer to the offspring through the placenta during the fetal period, and maternal IgM, IgG and IgA transfer via lactation during the neonatal period (<xref ref-type="bibr" rid="bib24">Gensollen et al., 2016</xref>; <xref ref-type="bibr" rid="bib36">Koch et al., 2016</xref>). Over time, newborns generate IgA that target immunogenic bacteria in the microbiota (<xref ref-type="bibr" rid="bib46">McLoughlin et al., 2016</xref>; <xref ref-type="bibr" rid="bib50">Moor et al., 2017</xref>), shaping its composition throughout adult life (<xref ref-type="bibr" rid="bib35">Kawamoto et al., 2014</xref>). We hypothesized that the mechanism via which <italic>Ggta1</italic> deletion shapes the gut microbiota involves targeting of immunogenic bacteria by both maternally- and offspring-derived immunoglobulins (Ig). To test this hypothesis, we used a similar experimental approach to that described above (<xref ref-type="fig" rid="fig1">Figure 1B</xref>; <xref ref-type="bibr" rid="bib69">Ubeda et al., 2012</xref>), whereby the microbiota from <italic>Ggta1<sup>+/+</sup></italic> mice was vertically transmitted to <italic>Ggta1<sup>+/+</sup></italic> or <italic>Ggta1<sup>-/-</sup></italic> offspring that express Ig (<italic>Igh-J<sup>+/+</sup></italic>) or not (<italic>Igh-J<sup>-/-</sup></italic>) (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). Crossing of F<sub>0</sub> <italic>Igh-J<sup>+/+</sup>Ggta1<sup>+/+</sup></italic> (female) with <italic>Igh-J<sup>-/-</sup>Ggta1<sup>-/-</sup></italic> (male) mice produced F<sub>1</sub> <italic>Igh-J<sup>+/-</sup>Ggta1<italic><sup>+/-</sup></italic></italic>mice, which were interbred to generate F<sub>2</sub> <italic>Igh-J<sup>+/+</sup>Ggta1<sup>+/+</sup></italic>, <italic>Igh-J<sup>+/+</sup>Ggta1<sup>-/-</sup>, Igh-J<sup>-/-</sup>Ggta1<sup>+/+</sup></italic> and <italic>Igh-J<sup>-/-</sup>Ggta1<sup>-/-</sup></italic> mice, harboring a microbiota composition indistinguishable among the genotypes (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A and B</xref>). Consistent with our previous observations (<xref ref-type="fig" rid="fig1">Figure 1C</xref>; <xref ref-type="bibr" rid="bib60">Singh et al., 2021</xref>), this suggests that maternal Ig transfer predominates over offspring Ig production in shaping the offspring microbiota, regardless of the genotype (<xref ref-type="bibr" rid="bib69">Ubeda et al., 2012</xref>).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title><italic>Ggta1</italic> deletion shapes the gut microbiota via an Ig-dependent mechanism.</title><p>(<bold>A</bold>) Breeding strategy where F<sub>0 </sub><italic>Igh-J<sup>-/-</sup>Ggta1<sup>-/-</sup></italic> males were crossed with <italic>Igh-J<sup>+/+</sup>Ggta1<sup>+/+</sup></italic> females to generate F<sub>1</sub> <italic>Igh-J<sup>+/-</sup>Ggta1<italic><sup>+/-</sup></italic></italic>mice, which were bred to generate F<sub>2</sub> and F<sub>3 </sub><italic>Igh-J<sup>+/+</sup>Ggta1<sup>+/+</sup>, Igh-J<sup>-/-</sup>Ggta1<sup>+/+</sup>, Igh-J<sup>+/+</sup>Ggta1<sup>-/-</sup>, and Igh-J<sup>-/-</sup>Ggta1<sup>-/-</sup></italic> mice. Microbiota Principal Coordinate Analysis of (<bold>B</bold>) Weighted and (<bold>C</bold>) Unweighted Unifrac and (<bold>D</bold>) Distance of Weighted and Unweighted Unifrac of 16S rRNA amplicons, in fecal samples from F<sub>3</sub> <italic>Igh-J<sup>+/+</sup>Ggta1<sup>+/+</sup></italic> (n = 13) <italic>vs. Igh-J<sup>-/-</sup>Ggta1<sup>+/+</sup></italic> (n = 16) mice and F<sub>3</sub> <italic>Igh-J<sup>+/+</sup>Ggta1<sup>-/-</sup></italic> (n = 13) <italic>vs. Igh-J<sup>-/-</sup>Ggta1<sup>-/-</sup></italic> (n = 11) mice generated as in (<bold>A</bold>). (<bold>E</bold>) Cladogram and (<bold>F</bold>) Linear discriminant analysis (LDA) scores generated from LEfSe analysis, representing taxa enriched in the fecal microbiota of the same mice as in (<bold>B–D</bold>). Data from one experiment with two to three independent breedings/cages per genotype. Symbols (<bold>B, C, D</bold>) are individual mice. Red bars (<bold>D</bold>) correspond to mean values. Error bars (<bold>D</bold>) correspond to SD. p Values in (<bold>B, C</bold>) calculated using PERMANOVA and in (<bold>D</bold>) using Mann-Whitney test. **p&lt;0.01, ns: not significant.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-67450-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title><italic>Ggta1</italic> deletion shapes the gut microbiota via an Ig-dependent mechanism.</title><p>Microbiota Principal Coordinate Analysis of (<bold>A</bold>) Weighted and Unweighted Unifrac and (<bold>B</bold>) Distance of Weighted and Unweighted Unifrac of 16S rRNA amplicons, in fecal samples from F<sub>2</sub> <italic>Igh-J<sup>+/+</sup>Ggta1<sup>+/+</sup></italic> (n = 8) <italic>vs. Igh-J<sup>-/-</sup>Ggta1<sup>+/+</sup></italic> (n = 11) mice and F<sub>2</sub> <italic>Igh-J<sup>+/+</sup>Ggta1<sup>-/-</sup></italic> (n = 5) <italic>vs. Igh-J<sup>-/-</sup>Ggta1<sup>-/-</sup></italic> (n = 8) mice generated as described in <xref ref-type="fig" rid="fig3">Figure 3A</xref>. (<bold>C–D</bold>) Cladogram and linear discriminant analysis (LDA) scores generated from LEfSe analysis, representing taxa enriched in the fecal microbiota of the same (<bold>C</bold>) F<sub>3</sub> <italic>Igh-J<sup>+/+</sup>Ggta1<sup>+/+</sup></italic> vs<italic>. Igh-J<sup>+/+</sup>Ggta1<sup>-/-</sup></italic> mice and (<bold>D</bold>) F<sub>3</sub> <italic>Igh-J<sup>-/-</sup>Ggta1<sup>+/+</sup> vs. Igh-J<sup>+/+</sup>Ggta1<sup>+/+</sup></italic> mice as in <xref ref-type="fig" rid="fig3">Figure 3B–D</xref>. Symbols (<bold>A, B</bold>) are individual mice. Red bars (<bold>B</bold>) correspond to mean values. Error bars (<bold>B</bold>) correspond to SD. p Values in (<bold>A</bold>) calculated using PERMANOVA and in (<bold>B</bold>) using Mann-Whitney test. ns: not significant.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-67450-fig3-figsupp1-v1.tif"/></fig></fig-group><p>To dissect the relative contribution of the <italic>Ggta1</italic> from the <italic>Ig</italic> genotype in shaping the microbiota, F<sub>2</sub> littermates were interbred to generate F<sub>3</sub> offspring carrying a microbiota targeted by antibodies (<italic>Igh-J<sup>+/+</sup>Ggta1<sup>+/+</sup></italic> and <italic>Igh-J<sup>+/+</sup>Ggta1<sup>-/-</sup></italic>) or not (<italic>Igh-J<sup>-/-</sup>Ggta1<sup>+/+</sup></italic> and <italic>Igh-J<sup>-/-</sup>Ggta1<sup>-/-</sup></italic>) (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). Consistent with our previous observations (<xref ref-type="fig" rid="fig1">Figure 1</xref>), there was a marked separation of the microbiota community structure between F<sub>3</sub> <italic>Igh-J<sup>+/+</sup>Ggta1<sup>-/-</sup> vs. Igh-J<sup>+/+</sup>Ggta1<sup>+/+</sup></italic> mice, as assessed by Principal Coordinate Analyses (PCA) for Weighted and Unweighted Unifrac (<xref ref-type="fig" rid="fig3">Figure 3B,C</xref>). Considering that Weighted Unifrac accounts for the relative abundance of the bacterial taxa while Unweighted Unifrac accounts for only the presence or absence of the taxa in the microbial community (<xref ref-type="bibr" rid="bib41">Lozupone and Knight, 2005</xref>), they represent differences exerted by high and low abundant bacterial taxa respectively. This suggests that <italic>Ggta1</italic> deletion shapes both high and low abundant taxa present in the microbiota when maternal and/or offspring-derived antibodies (i.e. Ig) are present.</p><p>LefSe analysis showed that the microbiota from <italic>Igh-J<sup>+/+</sup>Ggta1<sup>-/-</sup></italic> mice was enriched in specific bacterial taxa, including Proteobacteria, as compared to the microbiota from <italic>Igh-J<sup>+/+</sup>Ggta1<sup>+/+</sup></italic> mice (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1C</xref>). This suggests that <italic>Ggta1</italic> deletion favors gut colonization by pathobionts in an Ig-dependent manner.</p><p>We then asked whether Ig are functionally involved in shaping the microbiota composition of <italic>Ggta1<sup>-/-</sup> vs. Ggta1<sup>+/+</sup></italic> mice. In the absence of Ig (<italic>Igh-J<sup>-/-</sup></italic>), there were no differences in the microbiota composition of F<sub>3</sub> <italic>Igh-J<sup>-/-</sup>Ggta1<sup>-/-</sup> vs. Igh-J<sup>-/-</sup>Ggta1<sup>+/+</sup></italic> mice, as assessed by PCA for Weighted Unifrac (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). This suggests that shaping of highly abundant taxa in the microbiota of <italic>Ggta1<sup>-/-</sup> vs. Ggta1<sup>+/+</sup></italic> mice occurs via an Ig-dependent mechanism. In contrast, the microbiota composition of F<sub>3</sub> <italic>Igh-J<sup>-/-</sup>Ggta1<sup>-/-</sup></italic> mice remained distinct from that of <italic>Igh-J<sup>-/-</sup>Ggta1<sup>+/+</sup></italic> mice, as assessed by PCA for Unweighted Unifrac (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). This suggests that shaping of low abundance bacterial taxa in the microbiota of <italic>Ggta1<sup>-/-</sup> vs. Ggta1<sup>+/+</sup></italic> mice occurs in an Ig-independent manner.</p><p>To address the extent to which <italic>Ggta1</italic> deletion promotes shaping of the microbiota via an Ig-dependent mechanism, we compared the Unifrac distances between <italic>Igh-J<sup>+/+</sup>Ggta1<sup>+/+</sup></italic> and <italic>Igh-J<sup>-/-</sup>Ggta1<sup>+/+</sup></italic> mice <italic>vs. Igh-J<sup>+/+</sup>Ggta1<sup>-/-</sup></italic> and <italic>Igh-J<sup>-/-</sup>Ggta1<sup>-/-</sup></italic> mice, similar to what is previously described (<xref ref-type="bibr" rid="bib41">Lozupone and Knight, 2005</xref>). The Weighted Unifrac distance of microbiota from <italic>Igh-J<sup>+/+</sup>Ggta1<sup>-/-</sup></italic> v<italic>s. Igh-J<sup>-/-</sup>Ggta1<sup>-/-</sup></italic> mice was higher than that from <italic>Igh-J<sup>+/+</sup>Ggta1<sup>+/+</sup></italic> v<italic>s. Igh-J<sup>-/-</sup>Ggta1<sup>+/+</sup></italic> mice (<xref ref-type="fig" rid="fig3">Figure 3D</xref>). This suggests that the relative impact of Ig on the gut microbiota community structure exerted by highly abundant bacterial taxa is enhanced in <italic>Ggta1<sup>-/-</sup> vs. Ggta1<sup>+/+</sup></italic> mice. This was confirmed by LefSe analysis showing an enhanced Ig-dependent enrichment of several bacterial taxa in the microbiota of <italic>Ggta1<sup>-/-</sup></italic> mice (<xref ref-type="fig" rid="fig3">Figure 3E–F</xref>), compared to that of <italic>Ggta1<sup>+/+</sup></italic> mice (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1D</xref>). In contrast, the Unweighted Unifrac distance of <italic>Igh-J<sup>+/+</sup>Ggta1<sup>+/+</sup></italic> v<italic>s. Igh-J<sup>-/-</sup>Ggta1<sup>+/+</sup></italic> mice was higher compared to <italic>Igh-J<sup>+/+</sup>Ggta1<sup>-/-</sup></italic> v<italic>s. Igh-J<sup>-/-</sup>Ggta1<sup>-/-</sup></italic> mice (<xref ref-type="fig" rid="fig3">Figure 3D</xref>). This suggests that the relative impact of Ig on the microbiota community structure of low abundant bacterial taxa is less pronounced for <italic>Ggta1<sup>-/-</sup> vs. Ggta1<sup>+/+</sup></italic> mice.</p><p>We then asked whether Ig exert a higher impact on the relative abundance of pathobionts in the gut microbiota of <italic>Ggta1<sup>-/-</sup> vs. Ggta1<sup>+/+</sup></italic> mice. In strong support of this notion, the gut microbiota from <italic>Igh-J<sup>-/-</sup>Ggta1<sup>-/-</sup></italic> mice, lacking Ig, was enriched with Helicobactereaceae family from Proteobacteria phylum as compared to <italic>Igh-J<sup>+/+</sup>Ggta1<sup>-/-</sup></italic> mice expressing Ig (<xref ref-type="fig" rid="fig3">Figure 3E,F</xref>). This is consistent with our previous finding that the gut microbiota of <italic>Rag2<sup>-/-</sup>Ggta1<sup>-/-</sup></italic> mice, lacking adaptive immunity, is highly enriched in Proteobacteria, including <italic>Helicobacter</italic> (<xref ref-type="bibr" rid="bib60">Singh et al., 2021</xref>). Of note, this was not observed in <italic>Igh-J<sup>-/-</sup>Ggta1<sup>+/+</sup> vs. Igh-J<sup>+/+</sup>Ggta1<sup>+/+</sup></italic> mice (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1D</xref>). These data suggest that the absence of host αGal favors colonization of the gut microbiota by pathobionts, the expansion of which is restrained by Ig.</p></sec><sec id="s2-4"><title><italic>Ggta1</italic> deletion reduces microbiota pathogenicity</title><p>We then asked whether the Ig-dependent shaping of the microbiota in <italic>Ggta1<sup>-/-</sup></italic> mice affects the pathogenesis of sepsis due to systemic infections emanating from gut microbes. <italic>Ggta1<sup>-/-</sup></italic> mice were protected against systemic infections (i.p.) by a cecal inoculum isolated from <italic>Rag2<sup>-/-</sup>Ggta1<sup>-/-</sup></italic> mice, reflecting a microbiota not shaped by Ig (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A and B</xref>). This is consistent with our previous finding showing <italic>Ggta1</italic> deletion enhances protection against systemic bacterial infections (i.p.) via a mechanism involving IgG NAb (<xref ref-type="bibr" rid="bib60">Singh et al., 2021</xref>). Moreover, <italic>Ggta1<sup>-/-</sup></italic> mice were also protected against a systemic infection (i.p.) by a cecal inoculum isolated from <italic>Ggta1<sup>-/-</sup></italic> mice, reflecting their own Ig-shaped microbiota (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A and B</xref>). This is in keeping with the previously shown enhanced protection of <italic>Ggta1<sup>-/-</sup></italic> mice against cecal ligation and puncture (<xref ref-type="bibr" rid="bib60">Singh et al., 2021</xref>). Surprisingly <italic>Igh-J<sup>-/-</sup>Ggta1<sup>-/-</sup></italic> mice lacking B cells (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1C</xref>), <italic>Tcrb<sup>-/-</sup>Ggta1<sup>-/-</sup></italic> mice lacking α/β T cells (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1D</xref>) and <italic>Rag2<sup>-/-</sup>Ggta1<sup>-/-</sup></italic> mice lacking B and T cells (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1E</xref>) remained protected against systemic infections by the cecal inoculum isolated from <italic>Ggta1<sup>-/-</sup></italic> mice. This suggests that the previously described IgG-dependent mechanism that protects <italic>Ggta1<sup>-/-</sup></italic> mice from a systemic infection by a cecal inoculum isolated from <italic>Rag2<sup>-/-</sup>Ggta1<sup>-/-</sup></italic> mice (<xref ref-type="bibr" rid="bib60">Singh et al., 2021</xref>) is distinct from that protecting <italic>Ggta1<sup>-/-</sup></italic> mice from a systemic infection by their own cecal inoculum. We reasoned that this might be explained by a reduction of the overall pathogenicity of the Ig-shaped microbiota of <italic>Ggta1<sup>-/-</sup></italic> mice, compared to the non-Ig-shaped microbiota of <italic>Rag2<sup>-/-</sup>Ggta1<sup>-/-</sup></italic> mice. To test this hypothesis, we compared the outcome of <italic>Rag2<sup>-/-</sup>Ggta1<sup>-/-</sup></italic> mice upon a systemic infection by Ig-shaped <italic>vs.</italic> a non-Ig-shaped microbiota.</p><p><italic>Rag2<sup>-/-</sup>Ggta1<sup>-/-</sup></italic> mice remained protected against systemic infections by the cecal inoculum isolated from <italic>Ggta1<sup>-/-</sup></italic> mice, while succumbing to a systemic infection by a cecal inoculum isolated from <italic>Rag2<sup>-/-</sup>Ggta1<sup>-/-</sup></italic> mice (<xref ref-type="fig" rid="fig4">Figure 4A,B</xref>). Lethality was associated with a 10<sup>6</sup>–10<sup>7</sup>-fold increase in bacterial load (<xref ref-type="fig" rid="fig4">Figure 4C</xref>), suggesting that the Ig-shaped microbiota of <italic>Ggta1<sup>-/-</sup></italic> mice is less pathogenic, when compared to the non-Ig-shaped microbiota from <italic>Rag2<sup>-/-</sup>Ggta1<sup>-/-</sup></italic> mice.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title><italic>Ggta1</italic> deletion reduces microbiota pathogenicity.</title><p>(<bold>A</bold>) Schematic showing infection of <italic>Rag2<sup>-/-</sup>Ggta1<sup>-/-</sup></italic> mice with a cecal inoculum from either <italic>Ggta1<sup>-/-</sup></italic> or <italic>Rag2<sup>-/-</sup>Ggta1<sup>-/-</sup></italic> mice. (<bold>B</bold>) Survival of <italic>Rag2<sup>-/-</sup>Ggta1<sup>-/-</sup></italic> (n = 9) mice after infection with a cecal inoculum from <italic>Ggta1<sup>-/-</sup></italic> mice, and from <italic>Rag2<sup>-/-</sup>Ggta1<sup>-/-</sup></italic> (n = 9) mice after infection with a cecal inoculum from <italic>Rag2<sup>-/-</sup>Ggta1<sup>-/-</sup></italic> mice; two experiments. (<bold>C</bold>) Colony-forming units (CFU) of aerobic (Ae) and anaerobic (An) bacteria in <italic>Rag2<sup>-/-</sup>Ggta1<sup>-/-</sup></italic> mice (n = 5 per group), 24 hr after infection as in (<bold>B</bold>); two experiments. (<bold>D</bold>) Schematic showing infection of <italic>Rag2<sup>-/-</sup>Ggta1<sup>+/+</sup></italic> mice with a cecal inoculum from either <italic>Ggta1<sup>+/+</sup></italic> or <italic>Rag2<sup>-/-</sup>Ggta1<sup>+/+</sup></italic> mice. (<bold>E</bold>) Survival of <italic>Rag2<sup>-/-</sup>Ggta1<sup>+/+</sup></italic> (n = 5) mice after infection with a cecal inoculum from <italic>Ggta1<sup>+/+</sup></italic> mice, and <italic>Rag2<sup>-/-</sup> Ggta1<sup>+/+</sup></italic> (n = 5) mice after infection with a cecal inoculum from <italic>Rag2<sup>-/-</sup>Ggta1<sup>+/+</sup></italic> mice; one experiment. (<bold>F</bold>) CFU of Ae and An bacteria in <italic>Rag2<sup>-/-</sup>Ggta1<sup>-/-</sup></italic> mice (n = 4 per group), 24 hr after infection as in (<bold>E</bold>); one experiment. (<bold>G</bold>) Survival of <italic>Ggta1<sup>-/-</sup></italic> mice receiving vehicle (PBS) (n = 9) or Anti-Gr1 Ab (n = 8), 24 hr before infection with cecal inoculum from <italic>Ggta1<sup>-/-</sup></italic> mice; two experiments. (<bold>H</bold>) CFU of Ae and An bacteria in <italic>Ggta1<sup>-/-</sup></italic> mice receiving vehicle (PBS) (n = 4–5) or Anti-Gr1 Ab (n = 4–5), 24 hr after infection as in (<bold>G</bold>); five experiments. Symbols (<bold>C, F, H</bold>) represent individual mice. Red lines (<bold>C, F, H</bold>) correspond to median values. p Values in (<bold>B, E, G</bold>) calculated with log-rank test and in (<bold>C, F, H</bold>) with Mann-Whitney test. Peritoneal cavity (PC). *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, ns: not significant.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-67450-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title><italic>Ggta1</italic> deletion reduces microbiota pathogenicity.</title><p>(<bold>A</bold>) Schematic showing infection of <italic>Ggta1<sup>-/-</sup></italic> mice with a cecal inoculum from either <italic>Ggta1<sup>-/-</sup></italic> mice or <italic>Rag2<sup>-/-</sup>Ggta1<sup>-/-</sup></italic> mice. (<bold>B</bold>) Survival of <italic>Ggta1<sup>-/-</sup></italic> (n = 14) mice after infection with a cecal inoculum from <italic>Ggta1<sup>-/-</sup></italic> mice and of <italic>Ggta1<sup>-/-</sup></italic> (n = 13) mice after infection with a cecal inoculum from <italic>Rag2<sup>-/-</sup>Ggta1<sup>-/-</sup></italic> mice; two experiments. (<bold>C</bold>) Survival of <italic>Igh-J<sup>+/+</sup>Ggta1<sup>-/-</sup></italic> (n = 9) and <italic>Igh-J<sup>-/-</sup>Ggta1<sup>-/-</sup></italic> (n = 8) mice after infection with a cecal inoculum from <italic>Ggta1<sup>-/-</sup></italic> mice; two experiments. (<bold>D</bold>) Survival of <italic>Tcrb<sup>+/+</sup>Ggta1<sup>-/-</sup></italic> (n = 8) and <italic>Tcrb<sup>-/-</sup>Ggta1<sup>-/-</sup></italic> (n = 12) mice infected as in (<bold>C</bold>); two experiments. (<bold>E</bold>) Survival of <italic>Rag2<sup>+/+</sup>Ggta1<sup>-/-</sup></italic> (n = 9) and <italic>Rag2<sup>-/-</sup>Ggta1<sup>-/-</sup></italic> (n = 23) mice infected as in (<bold>C</bold>); five experiments. (<bold>F</bold>) Representative plots showing depletion of CD11b<sup>+</sup>Ly6G<sup>+</sup> cells in the blood 24 hr after Anti-Gr1 Ab injection (i.p.) in the same mice as in <xref ref-type="fig" rid="fig4">Figure 4G</xref>. (<bold>G</bold>) Representative plots showing depletion of CD11b<sup>+</sup>F4/80<sup>+</sup> and CD11b<sup>+</sup>Ly6C<sup>+</sup> cells in the peritoneal lavage 72 hr after injection (i.p.) with Clodronate liposomes. (<bold>H</bold>) Survival of <italic>Ggta1<sup>-/-</sup></italic> mice receiving PBS liposomes (n = 7) or Clodronate liposomes (n = 8), 72 hr before infection (i.p.) with cecal inoculum from <italic>Ggta1<sup>-/-</sup></italic> mice; two experiments. p Values in (<bold>B, C, D, E, H</bold>) calculated with log-rank test. Peritoneal cavity (PC). ns: not significant.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-67450-fig4-figsupp1-v1.tif"/></fig></fig-group><p>We then asked whether the reduction of microbiota pathogenicity imposed by the adaptive immune system of <italic>Ggta1<sup>-/-</sup></italic> mice is also operational in <italic>Ggta1<sup>+/+</sup></italic> mice. However, <italic>Rag2<sup>-/-</sup>Ggta1<sup>+/+</sup></italic> mice succumbed to the same extent to systemic infection (i.p.) with a cecal inoculum isolated from either <italic>Rag2<sup>+/+</sup>Ggta1<sup>+/+</sup> vs. Rag2<sup>-/-</sup>Ggta1<sup>+/+</sup></italic> mice (<xref ref-type="fig" rid="fig4">Figure 4D–E</xref>), developing similar bacterial loads (<xref ref-type="fig" rid="fig4">Figure 4F</xref>). This suggests that the mechanism via which the adaptive immune system of <italic>Ggta1<sup>-/-</sup></italic> mice shapes and reduces the pathogenicity of its microbiota is not operational in <italic>Ggta1<sup>+/+</sup></italic> mice.</p><p>Having established that in the absence of adaptive immunity, <italic>Ggta1<sup>-/-</sup></italic> mice are resistant against systemic infection by a low pathogenic Ig-shaped microbiota (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1C and E</xref>), we asked whether the mechanism of resistance relies on the innate immune system. Depletion of Ly6C<sup>+</sup>/Ly6G<sup>+</sup> myeloid cells (i.e. polymorphonuclear cells and inflammatory monocytes) using an anti-GR1 monoclonal Ab (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1F</xref>; <xref ref-type="bibr" rid="bib13">Daley et al., 2008</xref>) increased the susceptibility of <italic>Ggta1<sup>-/-</sup></italic> mice to systemic infection by their cecal inoculum (<xref ref-type="fig" rid="fig4">Figure 4G</xref>). This was associated with a 10<sup>2</sup>–10<sup>5</sup>-fold increase in bacterial load, compared to control <italic>Ggta1<sup>-/-</sup></italic> mice (<xref ref-type="fig" rid="fig4">Figure 4H</xref>). Of note, monocyte/macrophage depletion by Clodronate liposomes (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1G</xref>; <xref ref-type="bibr" rid="bib66">Sunderkötter et al., 2004</xref>) failed to compromise the survival of <italic>Ggta1<sup>-/-</sup></italic> mice upon infection by the same cecal inoculum (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1H</xref>). This suggests that polymorphonuclear cells are essential for resistance against systemic infection emanating from the less pathogenic Ig-shaped microbiota of <italic>Ggta1<sup>-/-</sup></italic> mice.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>While loss-of-function mutations in genes encoding glycosyltransferases can provide fitness advantages against infection, these can compromise the physiologic functions of the eliminated self-glycan, as illustrated by the occurrence of reproductive senescence upon <italic>Ggta1</italic> deletion in mice (<xref ref-type="bibr" rid="bib60">Singh et al., 2021</xref>). In an evolutionary context, such a trade-off could explain why loss-of-function mutations in these genes are rare, and in some cases unique, to the human lineage. The latter is illustrated by the loss of CMP-<italic>N</italic>-acetylneuraminic acid hydroxylase (<italic>CMAH</italic>) function, which eliminated expression of the sialic acid, <italic>N</italic>-glycolylneuraminic acid (Neu5Gc), in humans (<xref ref-type="bibr" rid="bib25">Ghaderi et al., 2011</xref>).</p><p>Co-evolution of ancestral hominids with commensal bacteria in their microbiota (<xref ref-type="bibr" rid="bib15">Dethlefsen et al., 2007</xref>; <xref ref-type="bibr" rid="bib33">Huttenhower et al., 2012</xref>; <xref ref-type="bibr" rid="bib48">Moeller et al., 2016</xref>), is thought to have provided a series of fitness advantages including, among others, optimization of nutrient intake from diet, regulation of different aspects of organismal metabolism or colonization resistance against pathogenic bacteria (<xref ref-type="bibr" rid="bib5">Buffie and Pamer, 2013</xref>). Here we propose that the loss of αGal expression, as it occurred during primate evolution, might have exerted a major impact on the nature of these symbiotic associations. In support of this notion, we found that <italic>Ggta1</italic> deletion in mice was associated with major changes in the composition of the gut microbiota (<xref ref-type="fig" rid="fig1">Figure 1</xref>). This occurred over several generations under experimental conditions of exposure to environmental-derived pathobionts, and minimum relative impact exerted by other environmental factors on microbiota composition (<xref ref-type="bibr" rid="bib69">Ubeda et al., 2012</xref>), arguing that the <italic>Ggta1</italic> genotype modulates the microbiota composition. On the basis of this observation alone (<xref ref-type="fig" rid="fig1">Figure 1</xref>), one cannot exclude the observed divergence in the microbiota bacterial population frequencies harbored by wild type vs. <italic>Ggta1</italic>-deleted mice (<xref ref-type="fig" rid="fig1">Figure 1</xref>) from being a stochastic event. However, the observation that these changes occur via an Ig-dependent mechanism that differs in wild type vs. <italic>Ggta1</italic>-deleted mice (<xref ref-type="fig" rid="fig3">Figure 3</xref>) does suggest that loss of αGal contributes critically to shape the microbiota composition of <italic>Ggta1-deleted </italic>mice.</p><p>While our studies do not provide direct evidence that the loss of αGal played a major role in shaping the microbiota composition of Old- <italic>vs.</italic> New World primates, this notion is supported, indirectly, by the recent finding that mutations altering the expression of human ABO blood group glycans are associated with shaping of the bacterial composition of the gut microbiota (<xref ref-type="bibr" rid="bib58">Rühlemann et al., 2021</xref>). In light of the structural similarity between the human B blood group (i.e. Galα1-3(Fucα1-2)Galβ1-4GlcNAcβ1-R), and αGal (i.e. Galα1-3Galβ1-4GlcNAcβ1-R) glycans, our findings probably reflect a general mechanism whereby host ‘αGal-like’ glycans shape the microbiota composition of mice and primates, including that of humans. Whether or not this is the case, considering that microbiota composition is shaped mostly by environmental factors, remains to be formally established.</p><p>The mechanism via which <italic>Ggta1</italic> deletion shapes the gut microbiota is associated with targeting of αGal-expressing bacteria by IgA (<xref ref-type="fig" rid="fig2">Figure 2</xref>). Consistent with this notion, a relatively large proportion of probiotic bacteria as well as bacteria present in the mouse microbiota express αGal-like glycans at the cell surface (<xref ref-type="fig" rid="fig2">Figure 2</xref>). About 30% of these carry IgA at the cell surface in the mouse microbiota and, as such, are considered as immunogenic (<xref ref-type="bibr" rid="bib52">Palm et al., 2014</xref>). The proportion of IgA<sup>+</sup>αGal<sup>+</sup> bacteria was reduced in the microbiota of <italic>Ggta1</italic>-deleted mice and was presumably eliminated (<xref ref-type="fig" rid="fig2">Figure 2</xref>). This suggests that <italic>Ggta1</italic> deletion probably broadens bacterial recognition by IgA to include immunogenic αGal<sup>+</sup> bacteria, which as a result are probably purged from the microbiota. Whether this occurs via a mechanism involving the recognition of αGal-like glycans, and/or other related epitopes expressed at the surface of these bacteria, by IgA, has not been established. Of note, these are not mutually exclusive possibilities since: (i) IgA can target αGal-like glycans and modulate bacterial pathogenicity (<xref ref-type="bibr" rid="bib31">Hamadeh et al., 1995</xref>), (ii) IgA are poly-reactive and can target common antigens expressed by bacteria (<xref ref-type="bibr" rid="bib7">Bunker et al., 2017</xref>; <xref ref-type="bibr" rid="bib6">Bunker et al., 2015</xref>) and (iii) αGal-reactive antibodies present a degree of poly-reactivity against non-αGal related bacterial epitopes (<xref ref-type="bibr" rid="bib4">Bernth Jensen et al., 2021</xref>).</p><p>The identity of the αGal<sup>+</sup> bacteria targeted by IgA remains elusive but likely includes Gram-negative pathobionts from the <italic>Enterobacteriaceae</italic> family, as demonstrated for <italic>Escherichia</italic> (<italic>E.</italic>) <italic>coli</italic> O86:B7 (<xref ref-type="bibr" rid="bib73">Yilmaz et al., 2014</xref>), which expresses the αGal-like glycan Galα1-3Gal(Fucα1–2)β1-3GlcNAcβ1-4Glc as part of the lipopolysaccharide (LPS) O-antigen (<xref ref-type="bibr" rid="bib28">Guo et al., 2005</xref>). Of note, this pathobiont can induce a systemic αGal-specific NAb response in humans (<xref ref-type="bibr" rid="bib64">Springer and Horton, 1969</xref>) as well as in <italic>Ggta1</italic>-deleted mice, which is protective against infection by pathogens expressing αGal-like glycans (<xref ref-type="bibr" rid="bib73">Yilmaz et al., 2014</xref>). The finding that several commensal bacteria in the human gut microbiota express αGal-like glycans (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>) suggests that other bacteria might contribute to this protective response.</p><p>Our findings also suggest that <italic>Ggta1</italic> deletion shapes the bacterial community structure among highly abundant bacterial taxa in the microbiota via an Ig-dependent mechanism, and among low abundant bacterial taxa independently of Ig (<xref ref-type="fig" rid="fig3">Figure 3</xref>). Presumably, shaping of highly abundant taxa by Ig occurs via a mechanism that involves not only IgA produced by the offspring, but also maternal IgG transferred through the placenta as well as IgM, IgG, and IgA transferred through maternal milk (<xref ref-type="bibr" rid="bib36">Koch et al., 2016</xref>). These regulate neonatal innate (<xref ref-type="bibr" rid="bib26">Gomez de Agüero et al., 2016</xref>) and adaptive (<xref ref-type="bibr" rid="bib36">Koch et al., 2016</xref>) immunity, shaping the offspring microbiota composition (<xref ref-type="bibr" rid="bib24">Gensollen et al., 2016</xref>; <xref ref-type="bibr" rid="bib36">Koch et al., 2016</xref>). Whether this occurs via targeting of αGal-like glycans, as discussed above, and/or via other bacterial antigens expressed by immunogenic bacteria has not been established.</p><p>Shaping of lowly abundant bacterial taxa independently of Ig (<xref ref-type="fig" rid="fig3">Figure 3</xref>) suggests that other mechanisms contribute to shaping the microbiota of <italic>Ggta1</italic>-deleted mice. These probably include the modulation of nutritional or spatial niches due to the loss of αGal from complex glycosylated structures present at epithelial barriers, such as the mucus, as demonstrated for other glycans (<xref ref-type="bibr" rid="bib54">Pickard et al., 2014</xref>).</p><p>The selective pressure exerted by the adaptive immune system of <italic>Ggta1<sup>-/-</sup></italic> mice on the bacterial species present in the microbiota, probably allows for the establishment of a more diverse ecosystem containing pathobionts (<xref ref-type="bibr" rid="bib60">Singh et al., 2021</xref>), such as Helicobactereaceae (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplements 1</xref> and <xref ref-type="fig" rid="fig1s2">2</xref>). These can elicit the production of antibodies targeting and exerting negative selective pressure on other bacterial symbionts and releasing ecological niches, thus further shaping the microbiota. Expansion of these pathobionts in the microbiota of <italic>Ggta1<sup>-/-</sup></italic> mice is restrained by Ig, which probably explains the lack of associated pathology (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3</xref>). This suggests that the loss of <italic>GGTA1</italic> function in ancestral primates fostered mutualistic interactions with more diverse bacterial ecosystems, incorporating pathobionts such as <italic>Helicobacter pylori</italic>, associated with fitness costs (<xref ref-type="bibr" rid="bib2">Atherton and Blaser, 2009</xref>) and gains (<xref ref-type="bibr" rid="bib40">Linz et al., 2007</xref>).</p><p>Our findings suggest that Ig-shaping of the bacterial species present in the gut microbiota of <italic>Ggta1<sup>-/-</sup></italic> mice reduces the microbiota pathogenicity, as illustrated when comparing the lethal outcome of systemic infections using the Ig-shaped <italic>vs.</italic> non-shaped microbiota (<xref ref-type="fig" rid="fig4">Figure 4A</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A and B</xref>). This reduction in pathogenicity means that the effector mechanism underlying resistance against systemic infection by the Ig-shaped microbiota no longer relies on the adaptive immune system (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1C and E</xref>), but instead on cellular components of the innate immune systems, namely, neutrophils (<xref ref-type="fig" rid="fig4">Figure 4G,H</xref>).</p><p>We propose that <italic>Ggta1</italic> deletion in mice increases resistance to bacterial sepsis via two distinct antibody-dependent mechanisms. The first involves a relative increase in antibody effector function, when αGal is not present in the biantennary glycan structures of IgG (<xref ref-type="bibr" rid="bib60">Singh et al., 2021</xref>). The second relies on shaping and reduction of the microbiota pathogenicity by antibodies, most likely from the IgA isotype. To what extent the lack of αGal from the biantennary glycan structures of Ig also contributes to shape and reduce the microbiota pathogenicity, remains to be established. It is possible however, that similar to IgG (<xref ref-type="bibr" rid="bib60">Singh et al., 2021</xref>), the absence of αGal from the glycan structures of different Ig isotypes, including IgA, modulates their effector function, when targeting immunogenic bacteria in the microbiota.</p><p>The notion of host mechanisms shaping the microbiota composition toward a reduction of its pathogenicity is in keeping with host microbial interactions not being hardwired, but instead shifting between symbiotic to pathogenic depending on host and microbe cooperative behaviors (<xref ref-type="bibr" rid="bib3">Ayres, 2016</xref>; <xref ref-type="bibr" rid="bib71">Vonaesch et al., 2018</xref>). For example, when restricted to the microbiota, bacterial pathobionts can behave as commensals, posing no pathogenic threat to the host (<xref ref-type="bibr" rid="bib71">Vonaesch et al., 2018</xref>), while triggering sepsis (<xref ref-type="bibr" rid="bib29">Haak and Wiersinga, 2017</xref>) upon translocation across epithelial barriers (<xref ref-type="bibr" rid="bib9">Caruso et al., 2020</xref>). The high fitness cost imposed to modern humans by sepsis (<xref ref-type="bibr" rid="bib57">Rudd et al., 2020</xref>) suggests that mutations shaping the composition of the microbiota toward a reduced capacity to elicit sepsis should be associated with major fitness advantages. Our findings suggest that loss-of-function mutations in <italic>GGTA1</italic> act in such a manner.</p><p>When challenged experimentally with a bacterial inoculum or bacterial lipopolysaccharide (LPS), non-human primates appear to be far more susceptible to develop sepsis or septic shock, respectively, as compared to other mammalian lineages (<xref ref-type="bibr" rid="bib11">Chen et al., 2019</xref>). This may appear at odds with our interpretation that similar to <italic>Ggta1</italic> deletion in mice (<xref ref-type="fig" rid="fig4">Figure 4</xref>; <xref ref-type="bibr" rid="bib60">Singh et al., 2021</xref>), the evolutionary loss of <italic>GGTA1</italic> function in Old-World primates might have increased resistance to bacterial sepsis (<xref ref-type="bibr" rid="bib60">Singh et al., 2021</xref>). One likely explanation for this apparent discrepancy may relate to the intrinsic properties of primate immunity, whereby natural selection of traits enhancing immune-driven resistance mechanisms (<xref ref-type="bibr" rid="bib51">Olson, 1999</xref>; <xref ref-type="bibr" rid="bib72">Wang et al., 2006</xref>) might be associated with lower capacity to establish disease tolerance to infection (<xref ref-type="bibr" rid="bib44">Martins et al., 2019</xref>; <xref ref-type="bibr" rid="bib47">Medzhitov et al., 2012</xref>). This interpretation is consistent with resistance and disease tolerance to infection being negatively correlated (<xref ref-type="bibr" rid="bib55">Råberg et al., 2007</xref>), such that traits increasing resistance might be associated with a reduction in disease tolerance, as an evolutionary trade-off.</p><p>In conclusion, protective immunity against αGal-expressing pathogens was likely a major driving force in the natural selective events that led to the fixation of loss-of-function mutations in the <italic>GGTA1</italic> gene of ancestral Old World primates (<xref ref-type="bibr" rid="bib21">Galili, 2016</xref>; <xref ref-type="bibr" rid="bib61">Soares and Yilmaz, 2016</xref>). Moreover, in the absence of αGal, the glycan structures associated with the Fc portion of IgG, can increase IgG-effector function and resistance to bacterial infections, irrespectively of αGal-specific immunity (<xref ref-type="bibr" rid="bib60">Singh et al., 2021</xref>). The net survival advantage against infection provided by these traits came alongside the emergence of reproductive senescence (<xref ref-type="bibr" rid="bib60">Singh et al., 2021</xref>), a major fitness cost presumably outweighed by endemic exposure to highly virulent pathogens (<xref ref-type="bibr" rid="bib60">Singh et al., 2021</xref>). Here we provide experimental evidence for yet another fitness advantage against infection, associated with the loss of <italic>GGTA1</italic>, driven by Ig-shaping and reduction of microbiota pathogenicity. We infer that ancestral Old World primates carrying loss-of-function mutations in <italic>GGTA1</italic> probably shaped their microbiota to minimize its pathogenic effect, providing a major fitness advantage against sepsis.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Mice</title><p>Mice were used in accordance with protocols approved by the Ethics Committee of the Instituto Gulbenkian de Ciência (IGC) and Direção Geral de Alimentação e Veterinária (DGAV), following the Portuguese (Decreto-Lei no. 113/2013) and European (directive 2010/63/EU) legislation for animal housing, husbandry, and welfare. C57BL/6J wild-type (<italic>Ggta1<sup>+/+</sup></italic>), <italic>Ggta1<sup>-/-</sup></italic> (<xref ref-type="bibr" rid="bib68">Tearle et al., 1996</xref>), <italic>Igh-J<sup>-/-</sup>Ggta1<sup>-/-</sup></italic> (<xref ref-type="bibr" rid="bib27">Gu et al., 1993</xref>)<italic>, Tcrb<sup>-/-</sup>Ggta1<sup>-/-</sup></italic> (<xref ref-type="bibr" rid="bib73">Yilmaz et al., 2014</xref>), <italic>Igha<sup>-/-</sup>Ggta1<sup>-/-</sup></italic> (<xref ref-type="bibr" rid="bib60">Singh et al., 2021</xref>), and <italic>Rag2<sup>-/-</sup>Ggta1<sup>-/-</sup></italic> (<xref ref-type="bibr" rid="bib60">Singh et al., 2021</xref>) mice were used. Mice were bred and maintained under specific pathogen-free (SPF) conditions (12 hr day/night, fed ad libitum), as described (<xref ref-type="bibr" rid="bib73">Yilmaz et al., 2014</xref>). Germ-free (GF) C57BL/6J <italic>Ggta1<sup>+/+</sup></italic> and <italic>Ggta1<sup>-/-</sup></italic> animals were bred and raised in the IGC gnotobiology facility in axenic isolators (La Calhene/ORM), as described (<xref ref-type="bibr" rid="bib73">Yilmaz et al., 2014</xref>; <xref ref-type="bibr" rid="bib60">Singh et al., 2021</xref>). Sterility of food, water, bedding, oral swab, and feces were confirmed as described (<xref ref-type="bibr" rid="bib60">Singh et al., 2021</xref>). Both male and female mice were used for all experiments. All animals were studied between 9–16 weeks of age unless otherwise indicated.</p></sec><sec id="s4-2"><title>Breeding experiments</title><p>Vertical transmission of the microbiota from <italic>Ggta1<sup>+/+</sup></italic> mice to <italic>Ggta1<sup>-/-</sup></italic> and <italic>Ggta1<sup>+/+</sup></italic> offspring over several generations was achieved, as described (<xref ref-type="bibr" rid="bib69">Ubeda et al., 2012</xref>; <xref ref-type="bibr" rid="bib60">Singh et al., 2021</xref>). Briefly, two or more breeding groups were established, consisting of two <italic>Ggta1<sup>+/+</sup></italic> females and one <italic>Ggta1<sup>-/-</sup></italic> male per cage. The male was removed after one week and the females were placed in a clean cage until delivery. F<sub>1</sub> <italic>Ggta1<sup>+/-</sup></italic> mice were weaned at 3–4 weeks of age and then co-housed until 8 weeks of age. Two or more F<sub>1</sub> <italic>Ggta1<sup>+/-</sup></italic> groups were established randomly using one male and two females per cage. F<sub>2</sub> pups were weaned at 3–4 weeks of age, genotyped and segregated according to their <italic>Ggta1<sup>-/-</sup> vs. Ggta1<sup>+/+</sup></italic> genotype in separate cages until adulthood. F<sub>3</sub> to F<sub>5</sub> pups were generated in a similar manner. Fecal pellets from two to three cages per genotype were collected (10–12 weeks of age) for microbiota analysis.</p><p>The effect of <italic>Ggta1</italic> genotype and Ig on microbiota composition derived from <italic>Ggta1<sup>+/+</sup></italic> mice was achieved essentially as described (<xref ref-type="bibr" rid="bib60">Singh et al., 2021</xref>). Briefly, two or more breeding groups were established, consisting of two <italic>Igh-J<sup>+/+</sup>Ggta1<sup>+/+</sup></italic> females and one <italic>Igh-J<sup>-/-</sup>Ggta1<sup>-/-</sup></italic> male per cage. The male was removed after 1 week and the females were placed in a clean cage until delivery. F<sub>1</sub> <italic>Igh-J<sup>+/-</sup>Ggta1<italic><sup>+/-</sup></italic> </italic>pups were kept with mothers until weaning at 3–4 weeks of age and co-housed until 8 weeks of age. Two or more F<sub>1</sub> <italic>Igh-J<sup>+/-</sup>Ggta1<italic><sup>+/-</sup></italic> </italic>breeding groups were established randomly using one male and two females per cage. Littermate F<sub>2</sub> pups were weaned at 3–4 weeks of age, genotyped and segregated according to their <italic>Igh-J<sup>+/+</sup>Ggta1<sup>-/-</sup></italic>, <italic>Igh-J<sup>-/-</sup>Ggta1<sup>-/-</sup></italic>, <italic>Igh-J<sup>+/+</sup>Ggta1<sup>+/+</sup></italic> and <italic>Igh-J<sup>-/-</sup>Ggta1<sup>+/+</sup></italic> genotypes in separate cages until adulthood. F<sub>3</sub> pups were generated in a similar manner. Fecal pellets from two to three cages per genotype were collected (10–12 weeks of age) for microbiota analysis.</p></sec><sec id="s4-3"><title>Genotyping</title><p>Mice were genotyped from tail biopsies (0.5–1 cm) by PCR of genomic DNA as per manufacturer’s protocols (KAPA mouse genotyping kit #KK7352) as described (<xref ref-type="bibr" rid="bib60">Singh et al., 2021</xref>).</p></sec><sec id="s4-4"><title>Cecal slurry injection</title><p>Cecal slurry injection was performed essentially as described (<xref ref-type="bibr" rid="bib60">Singh et al., 2021</xref>). Microbiota pathogenicity experiments were performed by preparing cecal slurry from <italic>Ggta1<sup>-/-</sup> vs. Rag2<sup>-/-</sup>Ggta1<sup>-/-</sup></italic> mice or from <italic>Ggta1<sup>+/+</sup> vs. Rag2<sup>-/-</sup>Ggta1<sup>+/+</sup></italic> mice and injecting to recipient mice (<italic>i.p.</italic> 1 mg/g body weight) in parallel. Mice were monitored every 12 hr for survival for 14 days or euthanized at various time points for analysis of different parameters.</p></sec><sec id="s4-5"><title>Pathogen load</title><p>Quantification of pathogen load in the mice was performed 24 hr after cecal slurry injection, essentially as described (<xref ref-type="bibr" rid="bib60">Singh et al., 2021</xref>).</p></sec><sec id="s4-6"><title>Neutrophil depletion</title><p>Anti-Gr1 mAb (Clone: RB6-8C5, 300 µg in 200 µL PBS) was injected (i.p.) to mice 24 hr before cecal slurry injection. Neutrophil depletion was confirmed by flow cytometry, using CD11b<sup>+</sup>Ly6G<sup>+</sup> cell staining in the blood.</p></sec><sec id="s4-7"><title>Monocyte/macrophage depletion</title><p>Clodronate or PBS liposomes (<ext-link ext-link-type="uri" xlink:href="http://www.Clodronateliposomes.org">http://www.Clodronateliposomes.org</ext-link>) was injected (10 µL/g, i.p.) to mice 72 hr before cecal slurry injection. Monocyte/macrophage depletion was confirmed by flow cytometry, using CD11b<sup>+</sup>F4/80<sup>+</sup> and CD11b<sup>+</sup>Ly6C<sup>+</sup> staining in the peritoneal lavage.</p></sec><sec id="s4-8"><title>ELISA</title><p>ELISA for IgA binding to cecal extracts was done essentially as described (<xref ref-type="bibr" rid="bib34">Kamada et al., 2015</xref>; <xref ref-type="bibr" rid="bib74">Zeng et al., 2016</xref>). Cecal lysate was prepared as described (<xref ref-type="bibr" rid="bib60">Singh et al., 2021</xref>). 96-well ELISA plates (Nunc MaxiSorp #442404) were coated with the cecal lysate (100 µL/well, 4°C, overnight), washed (3x, PBS 0.05% Tween-20, Sigma-Aldrich #P7949-500ML), blocked (200 µL, PBS 1% BSA wt/vol, Calbiochem #12659–100 GM, 3 hr, RT) and washed (3x, PBS 0.05% Tween-20). Plates were incubated with serially diluted (50 µL) mouse sera (1:20 to 1:100 in PBS 1% BSA, wt/vol, 2 hr, RT) and washed (5x, PBS/0.05% Tween-20). IgA was detected using horseradish peroxidase (HRP)-conjugated goat anti-mouse IgA (Southern Biotech #1040–05), in PBS/1%BSA/0.01% Tween-20 (100 µL, 1:4000 vol/vol, 1 hr, RT) and plates were washed (5x, PBS/0.05% Tween-20).</p><p>For quantification of total serum and small intestinal IgA, 96-well ELISA plates (Nunc MaxiSorp #442404) were coated with goat anti-mouse IgA (Southern Biotech #1040–01, 2 µg/mL in Carbonate-Bicarbonate buffer, 100 µL/well, overnight, 4°C), washed (3x, PBS 0.05% Tween-20, Sigma-Aldrich #P7949-500ML), blocked (200 µL, PBS 1% BSA wt/vol, 2 hr, RT) and washed (3x, PBS 0.05% Tween-20). Plates were incubated with serially diluted serum or gut content (50 µL, PBS 1% BSA, wt/vol, 2 hr, RT) and standard mouse IgA (Southern Biotech #0106–01, prepared in duplicates) and washed (5x, PBS/0.05% Tween-20). IgA was detected using HRP-conjugated goat anti-mouse IgA (Southern Biotech #1040–05) in PBS/1%BSA/0.01% Tween-20 (100 µL, 1:4000 vol/vol, 1 hr, RT) and plates were washed (5x, PBS/0.05% Tween-20).</p><p>For quantification of anti-αGal IgG, IgM and IgA, 96-well ELISA plates (Nunc MaxiSorp #442404) were coated with αGal-BSA (Dextra, 5 µg/mL in Carbonate-Bicarbonate buffer, 50 µL/well, overnight, 4°C). Wells were washed (3x, PBS 0.05% Tween-20, Sigma-Aldrich #P7949-500ML), blocked (200 µL, PBS 1% BSA wt/vol, 2 hr, RT) and washed (3x, PBS 0.05% Tween-20). Plates were incubated with serially diluted serum or fecal content (50 µL, PBS 1% BSA, wt/vol, 2 hr, RT) and standard mouse anti-αGal IgG, IgM or IgA and washed (5x, PBS/0.05% Tween-20). Anti-αGal Abs were detected using HRP-conjugated goat anti-mouse IgG, IgM, and IgA in PBS/1%BSA (100 µL, 1:4000 vol/vol, 1.5 hr, RT) and plates were washed (5x, PBS/0.05% Tween-20).</p><p>HRP activity was detected with 3,3′,5,5′-Tetramethylbenzidine (TMB) Substrate Reagent (BD Biosciences #555214, 50 µL, 20–25 min, dark, RT) and the reaction was stopped using sulfuric acid (2N, 50 µL). Optical densities (OD) were measured using a MultiSkan Go spectrophotometer (ThermoFisher) at λ = 450 nm and normalized by subtracting background OD values (λ = 600 nm).</p><p>For measurement of fecal Lipocalin (Lcn-2), feces were resuspended with sterile PBS (100 mg/mL), vortexed (5 min.), and centrifuged (12,000 rpm, 4°C, 10 min). Lcn-2 levels were determined in fecal supernatants using a LEGEND MAX Mouse NGAL (Lipocalin-2) ELISA Kit (BioLegend #443708).</p></sec><sec id="s4-9"><title>Flow cytometry of bacterial staining for IgA and αGal</title><p>Overnight cultures of bacteria were prepared as described in the next section. Samples of 5–20 µL of each bacterial culture depending on OD<sub>600</sub> measurements, and corresponding to approximately 10<sup>6</sup>–10<sup>7</sup> cells, were fixed in paraformaldehyde (PFA; 4% wt/vol in PBS) and washed with filter-sterilized PBS. For detection of IgA binding and αGal expression by gut microbes, small intestinal, cecal, colon and fecal samples were homogenized (5 mg/ml in PBS) by vortexing (maximum speed, 5 min, RT) and filtered (BD Falcon, 40 µm cell strainer # 352340). Larger debris were pelleted by centrifugation (600 g, 4°C, 5 min). Fifty μL supernatant (containing bacteria) per condition was added to a 96-well v-bottom plate (Corning Costar #3894) for staining. Bacteria were pelleted by centrifugation (3700 g, 10 min, 4°C) and suspended in flow cytometry buffer (filter-sterilized 1xPBS, 2% BSA, wt/vol). Bacterial DNA was stained using SYTO41 Blue Fluorescent Nucleic Acid Stain (Molecular Probes #S11352, 1:200 vol/vol, wt/vol) in flow cytometry buffer (100 µL, 30 min, RT). Cecal content from germ-free (GF) mice was used as control. Bacteria were washed in flow cytometry buffer (200 µL), centrifuged (4000 g, 10 min, 4°C) and supernatant was removed by flicking the plate. Bacteria were incubated in Fluorescein Isothiocyanate (FITC)-conjugated BSI-B4 lectin from <italic>Bandeiraea</italic> (<italic>Griffonia) simplicifolia</italic> (Sigma-Aldrich, #L2895-1MG, 50 µL, 40 µg/mL in PBS, 2 hr) for detection of αGal and anti-mouse IgA-PE mAb (mA-6E1, eBiosciences # 12-4204-82, 1:100 in PBS 2% BSA wt/vol, 30 min) and washed as above. <italic>E coli</italic> O86:B7 (about 10<sup>7</sup> per tube) was used as a positive control for bacterial αGal expression. Samples were re-suspended in flow cytometry buffer (300 µL), transferred to round-bottom tubes (BD Falcon #352235) and centrifuged (300 g, 1 min., RT). Samples were analyzed in LSR Fortessa SORP (BD Biosciences) equipped with a high-throughput sampler (HTS) using the FACSDiva Software (BD v.6.2) and analyzed by FlowJo software (v10.0.7) as described (<xref ref-type="bibr" rid="bib60">Singh et al., 2021</xref>).</p></sec><sec id="s4-10"><title>Detection of αGal expression by probiotic bacteria</title><p>Lyophilised stocks of probiotic strains of <italic>Bifidobacterium bifidum</italic> BB-G90, <italic>B. breve</italic> BBG95, <italic>B. infantis</italic> BIG201, <italic>B. longum</italic> BLG301, <italic>B. lactis</italic> BLG101<italic>, Lactobacillus bulgaricus</italic> LBG40, <italic>L. casei</italic> LCG11, <italic>L. cremoris</italic> LLCG42, <italic>L. lactis</italic> LLLG25, <italic>L. paracasei</italic> LPcG110, L. plantarum LPG18, <italic>L. reuteri</italic> LrG100, L. rhamnosus LrG14, L. salivarius LSG60, L. acidophilus LAG80, <italic>Streptococcus thermophilus</italic> STG30, <italic>L. helveticus</italic> LHG444, <italic>B. infantis</italic> BIG191, <italic>L. acidophilus</italic> LAG436, <italic>L. bulgaricus</italic> LBG058, <italic>L. bulgaricus</italic> LBG117, <italic>L. casei</italic> LCG402, <italic>L. plantarum</italic> LPG425, <italic>L. plantarum</italic> LPG429, <italic>L. plantarum</italic> LPG443, <italic>L. rhamnosus</italic> LrG426 (BioGrowing; <ext-link ext-link-type="uri" xlink:href="http://www.biogrowing.com/html/en/index.php?ac=article&amp;at=list&amp;tid=122">http://www.biogrowing.com/html/en/index.php?ac=article&amp;at=list&amp;tid=122</ext-link>), were resuspended in PBS (2 g/10 mL). Ten-fold serial dilutions in PBS were made and 100 μL plated onto MRS agar plates. Undiluted stock solutions were also streaked onto MRS agar plates. Bacteria were grown under anaerobic conditions using the GasPak EZ Anaerobe system (37°C, overnight). Cells from several independent colonies were selected and diluted in 200 μL PBS, fixed with PFA (50 μL, 16% solution, final concentration: 3.2% PFA, 30 min, 21°C), before being washed in PBS. Cells were stained in BSI-B<sub>4</sub>-FITC lectin (<italic>Bandeiraea</italic> (<italic>Griffonia</italic>) <italic>simplicifolia</italic> Isolectin B<sub>4</sub> (BSI-B<sub>4</sub>), FITC conjugate, L2895 SIGMA) (40 mg/mL, 45 min, 21°C, dark), before being washed in PBS and analyzed by flow cytometry using an LSR Fortessa SORP (BD), as described above. As positive and negative controls, <italic>Escherichia coli</italic> O86:B7 (ATCC 12701; Rockville, Md.), and <italic>E. coli</italic> K12 (ATCC 10798), respectively, were cultured in liquid Luria Bertani medium (37°C, overnight, aeration), washed twice (PBS; 4000 g; 5 min; 4°C) and re-suspended in PBS. Bacteria were fixed (200 μL; 4% PFA in PBS; 20–30 min; RT) and washed (1X; PBS; 4000 g; 5 min; RT). 10<sup>8</sup>–10<sup>9</sup> CFU/mL were stained with BSI-B<sub>4</sub>-FITC (200 μL; 40 μg/mL; 2 hr, RT) for flow cytometric analysis also as described above.</p></sec><sec id="s4-11"><title>Extraction of bacterial DNA from feces</title><p>Bacterial DNA was extracted from fecal pellets (QIAamp Fast DNA Stool Mini Kit #50951604) as described (<xref ref-type="bibr" rid="bib60">Singh et al., 2021</xref>).</p></sec><sec id="s4-12"><title>Amplicon sequencing: 16S amplicons sequencing and analysis</title><p>The 16S rRNA V4 region was amplified and sequenced following the Earth Microbiome Project (<ext-link ext-link-type="uri" xlink:href="http://www.earthmicrobiome.org/emp-standard-protocols/">http://www.earthmicrobiome.org/emp-standard-protocols/</ext-link>), and analyzed using QIIME 1.9.1 as described (<xref ref-type="bibr" rid="bib60">Singh et al., 2021</xref>). 16S sequencing data was submitted to the Sequence Read Archive (SRA), with the BioProject reference PRJNA701192 (accession code).</p></sec><sec id="s4-13"><title>Statistical analysis</title><p>Statistical tests were performed using GraphPad Prism Software (v.6.0). All statistical details, including statistical tests, exact value of n, what n represents, definition of center, dispersion and precision measures are provided in each figure legend.</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We thank our colleagues J Howard and I Gordo (Instituto Gulbenkian de Ciência; IGC) for critical review of the manuscript, IGC Genomics, Flow Cytometry, Antibody, Histopathology and Animal House Facilities. SS was supported by Fundação para a Ciência e Tecnologia (FCT; SFRH/BD/52177/2013), JAT by an ESCMID Research Grant and FCT (SFRH/BPD/112135/2015) and MPS by the Gulbenkian, ‘La Caixa’ (HR18-00502) and Bill and Melinda Gates (OPP1148170) Foundations, FCT (5723/2014 and FEDER029411). MPS is an associate member of the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) Cluster of Excellence ‘Balance of the Microverse’ (<ext-link ext-link-type="uri" xlink:href="https://microverse-cluster.de/en">https://microverse-cluster.de/en</ext-link>).</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Supervision, Funding acquisition, Investigation, Methodology, Writing - original draft, Project administration, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con3"><p>Formal analysis, Funding acquisition, Investigation, Methodology, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con4"><p>Data curation, Formal analysis</p></fn><fn fn-type="con" id="con5"><p>Data curation, Formal analysis, Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con6"><p>Formal analysis, Investigation, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con7"><p>Data curation, Software, Formal analysis, Investigation, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con8"><p>Conceptualization, Data curation, Formal analysis, Supervision, Funding acquisition, Investigation, Methodology, Writing - original draft, Project administration, Writing - review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other" id="fn1"><p>Animal experimentation: Mice were used in accordance with protocols approved by the Ethics Committee of the Instituto Gulbenkian de Ciência (IGC) and Direção Geral de Alimentação e Veterinária (DGAV), following the Portuguese (Decreto-Lei no. 113/2013) and European (directive 2010/63/EU) legislation for animal housing, husbandry and welfare.</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-67450-transrepform-v1.docx"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>All data generated during this study are included in the manuscript and supporting files. The 16S sequencing data can be accessed via NCBI Bioproject PRJNA701192.</p><p>The following dataset was generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Soares</surname><given-names>M</given-names></name><name><surname>Singh</surname><given-names>S</given-names></name><name><surname>Bastos-Amador</surname><given-names>P</given-names></name><name><surname>Thompson</surname><given-names>JA</given-names></name><name><surname>Yilmaz</surname><given-names>B</given-names></name><name><surname>Cardoso</surname><given-names>S</given-names></name><name><surname>Sobral</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2021">2021</year><data-title>GLYCAN-BASED SHAPING OF THE MICROBIOTA DURING PRIMATE EVOLUTION</data-title><source>NCBI BioProject</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/PRJNA701192">PRJNA701192</pub-id></element-citation></p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allison</surname> <given-names>AC</given-names></name></person-group><year iso-8601-date="1954">1954</year><article-title>Protection afforded by sickle-cell trait against subtertian malareal infection</article-title><source>BMJ</source><volume>1</volume><fpage>290</fpage><lpage>294</lpage><pub-id pub-id-type="doi">10.1136/bmj.1.4857.290</pub-id><pub-id pub-id-type="pmid">13115700</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atherton</surname> <given-names>JC</given-names></name><name><surname>Blaser</surname> <given-names>MJ</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Coadaptation of Helicobacter pylori and humans: ancient history, modern implications</article-title><source>Journal of Clinical Investigation</source><volume>119</volume><fpage>2475</fpage><lpage>2487</lpage><pub-id pub-id-type="doi">10.1172/JCI38605</pub-id><pub-id pub-id-type="pmid">19729845</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ayres</surname> <given-names>JS</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Cooperative microbial tolerance behaviors in Host-Microbiota mutualism</article-title><source>Cell</source><volume>165</volume><fpage>1323</fpage><lpage>1331</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.05.049</pub-id><pub-id pub-id-type="pmid">27259146</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bernth Jensen</surname> <given-names>JM</given-names></name><name><surname>Skeldal</surname> <given-names>S</given-names></name><name><surname>Petersen</surname> <given-names>MS</given-names></name><name><surname>Møller</surname> <given-names>BK</given-names></name><name><surname>Hoffmann</surname> <given-names>S</given-names></name><name><surname>Jensenius</surname> <given-names>JC</given-names></name><name><surname>Skov Sørensen</surname> <given-names>UB</given-names></name><name><surname>Thiel</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The human natural anti-αGal antibody targets common pathogens by broad-spectrum polyreactivity</article-title><source>Immunology</source><volume>162</volume><fpage>434</fpage><lpage>451</lpage><pub-id pub-id-type="doi">10.1111/imm.13297</pub-id><pub-id pub-id-type="pmid">33340093</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buffie</surname> <given-names>CG</given-names></name><name><surname>Pamer</surname> <given-names>EG</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Microbiota-mediated colonization resistance against intestinal pathogens</article-title><source>Nature Reviews Immunology</source><volume>13</volume><fpage>790</fpage><lpage>801</lpage><pub-id pub-id-type="doi">10.1038/nri3535</pub-id><pub-id pub-id-type="pmid">24096337</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bunker</surname> <given-names>JJ</given-names></name><name><surname>Flynn</surname> <given-names>TM</given-names></name><name><surname>Koval</surname> <given-names>JC</given-names></name><name><surname>Shaw</surname> <given-names>DG</given-names></name><name><surname>Meisel</surname> <given-names>M</given-names></name><name><surname>McDonald</surname> <given-names>BD</given-names></name><name><surname>Ishizuka</surname> <given-names>IE</given-names></name><name><surname>Dent</surname> <given-names>AL</given-names></name><name><surname>Wilson</surname> <given-names>PC</given-names></name><name><surname>Jabri</surname> <given-names>B</given-names></name><name><surname>Antonopoulos</surname> <given-names>DA</given-names></name><name><surname>Bendelac</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Innate and adaptive humoral responses coat distinct commensal Bacteria with immunoglobulin A</article-title><source>Immunity</source><volume>43</volume><fpage>541</fpage><lpage>553</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2015.08.007</pub-id><pub-id pub-id-type="pmid">26320660</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bunker</surname> <given-names>JJ</given-names></name><name><surname>Erickson</surname> <given-names>SA</given-names></name><name><surname>Flynn</surname> <given-names>TM</given-names></name><name><surname>Henry</surname> <given-names>C</given-names></name><name><surname>Koval</surname> <given-names>JC</given-names></name><name><surname>Meisel</surname> <given-names>M</given-names></name><name><surname>Jabri</surname> <given-names>B</given-names></name><name><surname>Antonopoulos</surname> <given-names>DA</given-names></name><name><surname>Wilson</surname> <given-names>PC</given-names></name><name><surname>Bendelac</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Natural polyreactive IgA antibodies coat the intestinal Microbiota</article-title><source>Science</source><volume>358</volume><elocation-id>eaan6619</elocation-id><pub-id pub-id-type="doi">10.1126/science.aan6619</pub-id><pub-id pub-id-type="pmid">28971969</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caporaso</surname> <given-names>JG</given-names></name><name><surname>Kuczynski</surname> <given-names>J</given-names></name><name><surname>Stombaugh</surname> <given-names>J</given-names></name><name><surname>Bittinger</surname> <given-names>K</given-names></name><name><surname>Bushman</surname> <given-names>FD</given-names></name><name><surname>Costello</surname> <given-names>EK</given-names></name><name><surname>Fierer</surname> <given-names>N</given-names></name><name><surname>Peña</surname> <given-names>AG</given-names></name><name><surname>Goodrich</surname> <given-names>JK</given-names></name><name><surname>Gordon</surname> <given-names>JI</given-names></name><name><surname>Huttley</surname> <given-names>GA</given-names></name><name><surname>Kelley</surname> <given-names>ST</given-names></name><name><surname>Knights</surname> <given-names>D</given-names></name><name><surname>Koenig</surname> <given-names>JE</given-names></name><name><surname>Ley</surname> <given-names>RE</given-names></name><name><surname>Lozupone</surname> <given-names>CA</given-names></name><name><surname>McDonald</surname> <given-names>D</given-names></name><name><surname>Muegge</surname> <given-names>BD</given-names></name><name><surname>Pirrung</surname> <given-names>M</given-names></name><name><surname>Reeder</surname> <given-names>J</given-names></name><name><surname>Sevinsky</surname> <given-names>JR</given-names></name><name><surname>Turnbaugh</surname> <given-names>PJ</given-names></name><name><surname>Walters</surname> <given-names>WA</given-names></name><name><surname>Widmann</surname> <given-names>J</given-names></name><name><surname>Yatsunenko</surname> <given-names>T</given-names></name><name><surname>Zaneveld</surname> <given-names>J</given-names></name><name><surname>Knight</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>QIIME allows analysis of high-throughput community sequencing data</article-title><source>Nature Methods</source><volume>7</volume><fpage>335</fpage><lpage>336</lpage><pub-id pub-id-type="doi">10.1038/nmeth.f.303</pub-id><pub-id pub-id-type="pmid">20383131</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caruso</surname> <given-names>R</given-names></name><name><surname>Lo</surname> <given-names>BC</given-names></name><name><surname>Núñez</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Host-microbiota interactions in inflammatory bowel disease</article-title><source>Nature Reviews Immunology</source><volume>20</volume><fpage>411</fpage><lpage>426</lpage><pub-id pub-id-type="doi">10.1038/s41577-019-0268-7</pub-id><pub-id pub-id-type="pmid">32005980</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chassaing</surname> <given-names>B</given-names></name><name><surname>Srinivasan</surname> <given-names>G</given-names></name><name><surname>Delgado</surname> <given-names>MA</given-names></name><name><surname>Young</surname> <given-names>AN</given-names></name><name><surname>Gewirtz</surname> <given-names>AT</given-names></name><name><surname>Vijay-Kumar</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Fecal lipocalin 2, a sensitive and broadly dynamic non-invasive biomarker for intestinal inflammation</article-title><source>PLOS ONE</source><volume>7</volume><elocation-id>e44328</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0044328</pub-id><pub-id pub-id-type="pmid">22957064</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>L</given-names></name><name><surname>Welty-Wolf</surname> <given-names>KE</given-names></name><name><surname>Kraft</surname> <given-names>BD</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Nonhuman primate species as models of human bacterial Sepsis</article-title><source>Lab Animal</source><volume>48</volume><fpage>57</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1038/s41684-018-0217-2</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chow</surname> <given-names>J</given-names></name><name><surname>Tang</surname> <given-names>H</given-names></name><name><surname>Mazmanian</surname> <given-names>SK</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Pathobionts of the gastrointestinal Microbiota and inflammatory disease</article-title><source>Current Opinion in Immunology</source><volume>23</volume><fpage>473</fpage><lpage>480</lpage><pub-id pub-id-type="doi">10.1016/j.coi.2011.07.010</pub-id><pub-id pub-id-type="pmid">21856139</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daley</surname> <given-names>JM</given-names></name><name><surname>Thomay</surname> <given-names>AA</given-names></name><name><surname>Connolly</surname> <given-names>MD</given-names></name><name><surname>Reichner</surname> <given-names>JS</given-names></name><name><surname>Albina</surname> <given-names>JE</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice</article-title><source>Journal of Leukocyte Biology</source><volume>83</volume><fpage>64</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1189/jlb.0407247</pub-id><pub-id pub-id-type="pmid">17884993</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeSantis</surname> <given-names>TZ</given-names></name><name><surname>Hugenholtz</surname> <given-names>P</given-names></name><name><surname>Larsen</surname> <given-names>N</given-names></name><name><surname>Rojas</surname> <given-names>M</given-names></name><name><surname>Brodie</surname> <given-names>EL</given-names></name><name><surname>Keller</surname> <given-names>K</given-names></name><name><surname>Huber</surname> <given-names>T</given-names></name><name><surname>Dalevi</surname> <given-names>D</given-names></name><name><surname>Hu</surname> <given-names>P</given-names></name><name><surname>Andersen</surname> <given-names>GL</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB</article-title><source>Applied and Environmental Microbiology</source><volume>72</volume><fpage>5069</fpage><lpage>5072</lpage><pub-id pub-id-type="doi">10.1128/AEM.03006-05</pub-id><pub-id pub-id-type="pmid">16820507</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dethlefsen</surname> <given-names>L</given-names></name><name><surname>McFall-Ngai</surname> <given-names>M</given-names></name><name><surname>Relman</surname> <given-names>DA</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>An ecological and evolutionary perspective on human-microbe mutualism and disease</article-title><source>Nature</source><volume>449</volume><fpage>811</fpage><lpage>818</lpage><pub-id pub-id-type="doi">10.1038/nature06245</pub-id><pub-id pub-id-type="pmid">17943117</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname> <given-names>JW</given-names></name><name><surname>Zhou</surname> <given-names>T</given-names></name><name><surname>Zeng</surname> <given-names>H</given-names></name><name><surname>Ma</surname> <given-names>L</given-names></name><name><surname>Verbeek</surname> <given-names>JS</given-names></name><name><surname>Yin</surname> <given-names>D</given-names></name><name><surname>Shen</surname> <given-names>J</given-names></name><name><surname>Chong</surname> <given-names>AS</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Hyperacute rejection by anti-Gal IgG1, IgG2a, and IgG2b is dependent on complement and Fc-gamma receptors</article-title><source>J Immunol. </source><volume>180</volume><fpage>261</fpage><lpage>268</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.180.1.261</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Donaldson</surname> <given-names>GP</given-names></name><name><surname>Ladinsky</surname> <given-names>MS</given-names></name><name><surname>Yu</surname> <given-names>KB</given-names></name><name><surname>Sanders</surname> <given-names>JG</given-names></name><name><surname>Yoo</surname> <given-names>BB</given-names></name><name><surname>Chou</surname> <given-names>WC</given-names></name><name><surname>Conner</surname> <given-names>ME</given-names></name><name><surname>Earl</surname> <given-names>AM</given-names></name><name><surname>Knight</surname> <given-names>R</given-names></name><name><surname>Bjorkman</surname> <given-names>PJ</given-names></name><name><surname>Mazmanian</surname> <given-names>SK</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Gut Microbiota utilize immunoglobulin A for mucosal colonization</article-title><source>Science</source><volume>360</volume><fpage>795</fpage><lpage>800</lpage><pub-id pub-id-type="doi">10.1126/science.aaq0926</pub-id><pub-id pub-id-type="pmid">29724905</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fagarasan</surname> <given-names>S</given-names></name><name><surname>Kawamoto</surname> <given-names>S</given-names></name><name><surname>Kanagawa</surname> <given-names>O</given-names></name><name><surname>Suzuki</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Adaptive immune regulation in the gut: t cell-dependent and T cell-independent IgA synthesis</article-title><source>Annual Review of Immunology</source><volume>28</volume><fpage>243</fpage><lpage>273</lpage><pub-id pub-id-type="doi">10.1146/annurev-immunol-030409-101314</pub-id><pub-id pub-id-type="pmid">20192805</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galili</surname> <given-names>U</given-names></name><name><surname>Clark</surname> <given-names>MR</given-names></name><name><surname>Shohet</surname> <given-names>SB</given-names></name><name><surname>Buehler</surname> <given-names>J</given-names></name><name><surname>Macher</surname> <given-names>BA</given-names></name></person-group><year iso-8601-date="1987">1987</year><article-title>Evolutionary relationship between the natural anti-Gal antibody and the gal alpha 1----3gal epitope in primates</article-title><source>PNAS</source><volume>84</volume><fpage>1369</fpage><lpage>1373</lpage><pub-id pub-id-type="doi">10.1073/pnas.84.5.1369</pub-id><pub-id pub-id-type="pmid">2434954</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galili</surname> <given-names>U</given-names></name><name><surname>Shohet</surname> <given-names>SB</given-names></name><name><surname>Kobrin</surname> <given-names>E</given-names></name><name><surname>Stults</surname> <given-names>CL</given-names></name><name><surname>Macher</surname> <given-names>BA</given-names></name></person-group><year iso-8601-date="1988">1988</year><article-title>Man, apes, and old world monkeys differ from other mammals in the expression of alpha-galactosyl epitopes on nucleated cells</article-title><source>Journal of Biological Chemistry</source><volume>263</volume><fpage>17755</fpage><lpage>17762</lpage><pub-id pub-id-type="doi">10.1016/S0021-9258(19)77900-9</pub-id><pub-id pub-id-type="pmid">2460463</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galili</surname> <given-names>U</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Natural anti-carbohydrate antibodies contributing to evolutionary survival of primates in viral epidemics?</article-title><source>Glycobiology</source><volume>142</volume><fpage>1140</fpage><lpage>1150</lpage><pub-id pub-id-type="doi">10.1093/glycob/cww088</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galili</surname> <given-names>U</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Evolution in primates by &quot;Catastrophic-selection&quot; interplay between enveloped virus epidemics, mutated genes of enzymes synthesizing carbohydrate antigens, and natural anti-carbohydrate antibodies</article-title><source>American Journal of Physical Anthropology</source><volume>168</volume><fpage>352</fpage><lpage>363</lpage><pub-id pub-id-type="doi">10.1002/ajpa.23745</pub-id><pub-id pub-id-type="pmid">30578545</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gálvez</surname> <given-names>EJC</given-names></name><name><surname>Iljazovic</surname> <given-names>A</given-names></name><name><surname>Gronow</surname> <given-names>A</given-names></name><name><surname>Flavell</surname> <given-names>R</given-names></name><name><surname>Strowig</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Shaping of intestinal Microbiota in Nlrp6- and Rag2-Deficient mice depends on community structure</article-title><source>Cell Reports</source><volume>21</volume><fpage>3914</fpage><lpage>3926</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2017.12.027</pub-id><pub-id pub-id-type="pmid">29281837</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gensollen</surname> <given-names>T</given-names></name><name><surname>Iyer</surname> <given-names>SS</given-names></name><name><surname>Kasper</surname> <given-names>DL</given-names></name><name><surname>Blumberg</surname> <given-names>RS</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>How colonization by Microbiota in early life shapes the immune system</article-title><source>Science</source><volume>352</volume><fpage>539</fpage><lpage>544</lpage><pub-id pub-id-type="doi">10.1126/science.aad9378</pub-id><pub-id pub-id-type="pmid">27126036</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghaderi</surname> <given-names>D</given-names></name><name><surname>Springer</surname> <given-names>SA</given-names></name><name><surname>Ma</surname> <given-names>F</given-names></name><name><surname>Cohen</surname> <given-names>M</given-names></name><name><surname>Secrest</surname> <given-names>P</given-names></name><name><surname>Taylor</surname> <given-names>RE</given-names></name><name><surname>Varki</surname> <given-names>A</given-names></name><name><surname>Gagneux</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Sexual selection by female immunity against paternal antigens can fix loss of function alleles</article-title><source>PNAS</source><volume>108</volume><fpage>17743</fpage><lpage>17748</lpage><pub-id pub-id-type="doi">10.1073/pnas.1102302108</pub-id><pub-id pub-id-type="pmid">21987817</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomez de Agüero</surname> <given-names>M</given-names></name><name><surname>Ganal-Vonarburg</surname> <given-names>SC</given-names></name><name><surname>Fuhrer</surname> <given-names>T</given-names></name><name><surname>Rupp</surname> <given-names>S</given-names></name><name><surname>Uchimura</surname> <given-names>Y</given-names></name><name><surname>Li</surname> <given-names>H</given-names></name><name><surname>Steinert</surname> <given-names>A</given-names></name><name><surname>Heikenwalder</surname> <given-names>M</given-names></name><name><surname>Hapfelmeier</surname> <given-names>S</given-names></name><name><surname>Sauer</surname> <given-names>U</given-names></name><name><surname>McCoy</surname> <given-names>KD</given-names></name><name><surname>Macpherson</surname> <given-names>AJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The maternal Microbiota drives early postnatal innate immune development</article-title><source>Science</source><volume>351</volume><fpage>1296</fpage><lpage>1302</lpage><pub-id pub-id-type="doi">10.1126/science.aad2571</pub-id><pub-id pub-id-type="pmid">26989247</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname> <given-names>H</given-names></name><name><surname>Zou</surname> <given-names>YR</given-names></name><name><surname>Rajewsky</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Independent control of immunoglobulin switch recombination at individual switch regions evidenced through Cre-loxP-mediated gene targeting</article-title><source>Cell</source><volume>73</volume><fpage>1155</fpage><lpage>1164</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(93)90644-6</pub-id><pub-id pub-id-type="pmid">8513499</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname> <given-names>H</given-names></name><name><surname>Yi</surname> <given-names>W</given-names></name><name><surname>Shao</surname> <given-names>J</given-names></name><name><surname>Lu</surname> <given-names>Y</given-names></name><name><surname>Zhang</surname> <given-names>W</given-names></name><name><surname>Song</surname> <given-names>J</given-names></name><name><surname>Wang</surname> <given-names>PG</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Molecular analysis of the O-antigen gene cluster of <italic>Escherichia coli</italic> O86:b7 and characterization of the chain length determinant gene (wzz)</article-title><source>Applied and Environmental Microbiology</source><volume>71</volume><fpage>7995</fpage><lpage>8001</lpage><pub-id pub-id-type="doi">10.1128/AEM.71.12.7995-8001.2005</pub-id><pub-id pub-id-type="pmid">16332778</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haak</surname> <given-names>BW</given-names></name><name><surname>Wiersinga</surname> <given-names>WJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The role of the gut Microbiota in Sepsis</article-title><source>The Lancet Gastroenterology &amp; Hepatology</source><volume>2</volume><fpage>135</fpage><lpage>143</lpage><pub-id pub-id-type="doi">10.1016/S2468-1253(16)30119-4</pub-id><pub-id pub-id-type="pmid">28403983</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haldane</surname> <given-names>JBS</given-names></name></person-group><year iso-8601-date="1949">1949</year><article-title>Disease and evolution</article-title><source>Ricerca Scientifica</source><volume>19</volume><fpage>68</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1007/0-387-28295-5_9</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamadeh</surname> <given-names>RM</given-names></name><name><surname>Estabrook</surname> <given-names>MM</given-names></name><name><surname>Zhou</surname> <given-names>P</given-names></name><name><surname>Jarvis</surname> <given-names>GA</given-names></name><name><surname>Griffiss</surname> <given-names>JM</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Anti-Gal binds to pili of Neisseria meningitidis: the immunoglobulin A isotype blocks complement-mediated killing</article-title><source>Infection and Immunity</source><volume>63</volume><fpage>4900</fpage><lpage>4906</lpage><pub-id pub-id-type="doi">10.1128/IAI.63.12.4900-4906.1995</pub-id><pub-id pub-id-type="pmid">7591153</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hooper</surname> <given-names>LV</given-names></name><name><surname>Littman</surname> <given-names>DR</given-names></name><name><surname>Macpherson</surname> <given-names>AJ</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Interactions between the Microbiota and the immune system</article-title><source>Science</source><volume>336</volume><fpage>1268</fpage><lpage>1273</lpage><pub-id pub-id-type="doi">10.1126/science.1223490</pub-id><pub-id pub-id-type="pmid">22674334</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huttenhower</surname> <given-names>C</given-names></name><name><surname>Gevers</surname> <given-names>D</given-names></name><name><surname>Knight</surname> <given-names>R</given-names></name><name><surname>Abubucker</surname> <given-names>S</given-names></name><name><surname>Badger</surname> <given-names>JH</given-names></name><name><surname>Chinwalla</surname> <given-names>AT</given-names></name><name><surname>Creasy</surname> <given-names>HH</given-names></name><name><surname>Earl</surname> <given-names>AM</given-names></name><name><surname>FitzGerald</surname> <given-names>MG</given-names></name><name><surname>Fulton</surname> <given-names>RS</given-names></name><collab>Human Microbiome Project Consortium</collab></person-group><year iso-8601-date="2012">2012</year><article-title>Structure, function and diversity of the healthy human microbiome</article-title><source>Nature</source><volume>486</volume><fpage>207</fpage><lpage>214</lpage><pub-id pub-id-type="doi">10.1038/nature11234</pub-id><pub-id pub-id-type="pmid">22699609</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamada</surname> <given-names>N</given-names></name><name><surname>Sakamoto</surname> <given-names>K</given-names></name><name><surname>Seo</surname> <given-names>SU</given-names></name><name><surname>Zeng</surname> <given-names>MY</given-names></name><name><surname>Kim</surname> <given-names>YG</given-names></name><name><surname>Cascalho</surname> <given-names>M</given-names></name><name><surname>Vallance</surname> <given-names>BA</given-names></name><name><surname>Puente</surname> <given-names>JL</given-names></name><name><surname>Núñez</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Humoral immunity in the gut selectively targets phenotypically virulent Attaching-and-Effacing Bacteria for intraluminal elimination</article-title><source>Cell Host &amp; Microbe</source><volume>17</volume><fpage>617</fpage><lpage>627</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2015.04.001</pub-id><pub-id pub-id-type="pmid">25936799</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawamoto</surname> <given-names>S</given-names></name><name><surname>Maruya</surname> <given-names>M</given-names></name><name><surname>Kato</surname> <given-names>LM</given-names></name><name><surname>Suda</surname> <given-names>W</given-names></name><name><surname>Atarashi</surname> <given-names>K</given-names></name><name><surname>Doi</surname> <given-names>Y</given-names></name><name><surname>Tsutsui</surname> <given-names>Y</given-names></name><name><surname>Qin</surname> <given-names>H</given-names></name><name><surname>Honda</surname> <given-names>K</given-names></name><name><surname>Okada</surname> <given-names>T</given-names></name><name><surname>Hattori</surname> <given-names>M</given-names></name><name><surname>Fagarasan</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Foxp3+ T cells regulate immunoglobulin A selection and facilitate diversification of bacterial species responsible for immune homeostasis</article-title><source>Immunity</source><volume>41</volume><fpage>152</fpage><lpage>165</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2014.05.016</pub-id><pub-id pub-id-type="pmid">25017466</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koch</surname> <given-names>MA</given-names></name><name><surname>Reiner</surname> <given-names>GL</given-names></name><name><surname>Lugo</surname> <given-names>KA</given-names></name><name><surname>Kreuk</surname> <given-names>LS</given-names></name><name><surname>Stanbery</surname> <given-names>AG</given-names></name><name><surname>Ansaldo</surname> <given-names>E</given-names></name><name><surname>Seher</surname> <given-names>TD</given-names></name><name><surname>Ludington</surname> <given-names>WB</given-names></name><name><surname>Barton</surname> <given-names>GM</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Maternal IgG and IgA antibodies dampen mucosal T helper cell responses in early life</article-title><source>Cell</source><volume>165</volume><fpage>827</fpage><lpage>841</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.04.055</pub-id><pub-id pub-id-type="pmid">27153495</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kubinak</surname> <given-names>JL</given-names></name><name><surname>Round</surname> <given-names>JL</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Do antibodies select a healthy Microbiota?</article-title><source>Nature Reviews Immunology</source><volume>16</volume><fpage>767</fpage><lpage>774</lpage><pub-id pub-id-type="doi">10.1038/nri.2016.114</pub-id><pub-id pub-id-type="pmid">27818504</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lane-Petter</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="1962">1962</year><article-title>The provision and use of Pathogen-Free laboratory animals</article-title><source>PNAS</source><volume>55</volume><fpage>253</fpage><lpage>263</lpage><pub-id pub-id-type="doi">10.1177/003591576205500402</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="1962">1962</year><article-title>Catastrophic selection as a factor in speciation</article-title><source>Evolution</source><volume>16</volume><fpage>257</fpage><lpage>271</lpage><pub-id pub-id-type="doi">10.1111/j.1558-5646.1962.tb03218.x</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Linz</surname> <given-names>B</given-names></name><name><surname>Balloux</surname> <given-names>F</given-names></name><name><surname>Moodley</surname> <given-names>Y</given-names></name><name><surname>Manica</surname> <given-names>A</given-names></name><name><surname>Liu</surname> <given-names>H</given-names></name><name><surname>Roumagnac</surname> <given-names>P</given-names></name><name><surname>Falush</surname> <given-names>D</given-names></name><name><surname>Stamer</surname> <given-names>C</given-names></name><name><surname>Prugnolle</surname> <given-names>F</given-names></name><name><surname>van der Merwe</surname> <given-names>SW</given-names></name><name><surname>Yamaoka</surname> <given-names>Y</given-names></name><name><surname>Graham</surname> <given-names>DY</given-names></name><name><surname>Perez-Trallero</surname> <given-names>E</given-names></name><name><surname>Wadstrom</surname> <given-names>T</given-names></name><name><surname>Suerbaum</surname> <given-names>S</given-names></name><name><surname>Achtman</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>An african origin for the intimate association between humans and Helicobacter pylori</article-title><source>Nature</source><volume>445</volume><fpage>915</fpage><lpage>918</lpage><pub-id pub-id-type="doi">10.1038/nature05562</pub-id><pub-id pub-id-type="pmid">17287725</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lozupone</surname> <given-names>C</given-names></name><name><surname>Knight</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>UniFrac: a new phylogenetic method for comparing microbial communities</article-title><source>Applied and Environmental Microbiology</source><volume>71</volume><fpage>8228</fpage><lpage>8235</lpage><pub-id pub-id-type="doi">10.1128/AEM.71.12.8228-8235.2005</pub-id><pub-id pub-id-type="pmid">16332807</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Macpherson</surname> <given-names>AJ</given-names></name><name><surname>Gatto</surname> <given-names>D</given-names></name><name><surname>Sainsbury</surname> <given-names>E</given-names></name><name><surname>Harriman</surname> <given-names>GR</given-names></name><name><surname>Hengartner</surname> <given-names>H</given-names></name><name><surname>Zinkernagel</surname> <given-names>RM</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal Bacteria</article-title><source>Science</source><volume>288</volume><fpage>2222</fpage><lpage>2226</lpage><pub-id pub-id-type="doi">10.1126/science.288.5474.2222</pub-id><pub-id pub-id-type="pmid">10864873</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Macpherson</surname> <given-names>AJ</given-names></name><name><surname>Yilmaz</surname> <given-names>B</given-names></name><name><surname>Limenitakis</surname> <given-names>JP</given-names></name><name><surname>Ganal-Vonarburg</surname> <given-names>SC</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>IgA function in relation to the intestinal Microbiota</article-title><source>Annual Review of Immunology</source><volume>36</volume><fpage>359</fpage><lpage>381</lpage><pub-id pub-id-type="doi">10.1146/annurev-immunol-042617-053238</pub-id><pub-id pub-id-type="pmid">29400985</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martins</surname> <given-names>R</given-names></name><name><surname>Carlos</surname> <given-names>AR</given-names></name><name><surname>Braza</surname> <given-names>F</given-names></name><name><surname>Thompson</surname> <given-names>JA</given-names></name><name><surname>Bastos-Amador</surname> <given-names>P</given-names></name><name><surname>Ramos</surname> <given-names>S</given-names></name><name><surname>Soares</surname> <given-names>MP</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Disease tolerance as an inherent component of immunity</article-title><source>Annual Review of Immunology</source><volume>37</volume><fpage>405</fpage><lpage>437</lpage><pub-id pub-id-type="doi">10.1146/annurev-immunol-042718-041739</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McFall-Ngai</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Care for the community</article-title><source>Nature</source><volume>445</volume><elocation-id>153</elocation-id><pub-id pub-id-type="doi">10.1038/445153a</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McLoughlin</surname> <given-names>K</given-names></name><name><surname>Schluter</surname> <given-names>J</given-names></name><name><surname>Rakoff-Nahoum</surname> <given-names>S</given-names></name><name><surname>Smith</surname> <given-names>AL</given-names></name><name><surname>Foster</surname> <given-names>KR</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Host selection of Microbiota via differential adhesion</article-title><source>Cell Host &amp; Microbe</source><volume>19</volume><fpage>550</fpage><lpage>559</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2016.02.021</pub-id><pub-id pub-id-type="pmid">27053168</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Medzhitov</surname> <given-names>R</given-names></name><name><surname>Schneider</surname> <given-names>DS</given-names></name><name><surname>Soares</surname> <given-names>MP</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Disease tolerance as a defense strategy</article-title><source>Science</source><volume>335</volume><fpage>936</fpage><lpage>941</lpage><pub-id pub-id-type="doi">10.1126/science.1214935</pub-id><pub-id pub-id-type="pmid">22363001</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moeller</surname> <given-names>AH</given-names></name><name><surname>Caro-Quintero</surname> <given-names>A</given-names></name><name><surname>Mjungu</surname> <given-names>D</given-names></name><name><surname>Georgiev</surname> <given-names>AV</given-names></name><name><surname>Lonsdorf</surname> <given-names>EV</given-names></name><name><surname>Muller</surname> <given-names>MN</given-names></name><name><surname>Pusey</surname> <given-names>AE</given-names></name><name><surname>Peeters</surname> <given-names>M</given-names></name><name><surname>Hahn</surname> <given-names>BH</given-names></name><name><surname>Ochman</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Cospeciation of gut Microbiota with hominids</article-title><source>Science</source><volume>353</volume><fpage>380</fpage><lpage>382</lpage><pub-id pub-id-type="doi">10.1126/science.aaf3951</pub-id><pub-id pub-id-type="pmid">27463672</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montassier</surname> <given-names>E</given-names></name><name><surname>Al-Ghalith</surname> <given-names>GA</given-names></name><name><surname>Mathé</surname> <given-names>C</given-names></name><name><surname>Le Bastard</surname> <given-names>Q</given-names></name><name><surname>Douillard</surname> <given-names>V</given-names></name><name><surname>Garnier</surname> <given-names>A</given-names></name><name><surname>Guimon</surname> <given-names>R</given-names></name><name><surname>Raimondeau</surname> <given-names>B</given-names></name><name><surname>Touchefeu</surname> <given-names>Y</given-names></name><name><surname>Duchalais</surname> <given-names>E</given-names></name><name><surname>Vince</surname> <given-names>N</given-names></name><name><surname>Limou</surname> <given-names>S</given-names></name><name><surname>Gourraud</surname> <given-names>PA</given-names></name><name><surname>Laplaud</surname> <given-names>DA</given-names></name><name><surname>Nicot</surname> <given-names>AB</given-names></name><name><surname>Soulillou</surname> <given-names>JP</given-names></name><name><surname>Berthelot</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Distribution of bacterial α1,3-Galactosyltransferase genes in the human gut microbiome</article-title><source>Frontiers in Immunology</source><volume>10</volume><elocation-id>3000</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2019.03000</pub-id><pub-id pub-id-type="pmid">31998300</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moor</surname> <given-names>K</given-names></name><name><surname>Diard</surname> <given-names>M</given-names></name><name><surname>Sellin</surname> <given-names>ME</given-names></name><name><surname>Felmy</surname> <given-names>B</given-names></name><name><surname>Wotzka</surname> <given-names>SY</given-names></name><name><surname>Toska</surname> <given-names>A</given-names></name><name><surname>Bakkeren</surname> <given-names>E</given-names></name><name><surname>Arnoldini</surname> <given-names>M</given-names></name><name><surname>Bansept</surname> <given-names>F</given-names></name><name><surname>Co</surname> <given-names>AD</given-names></name><name><surname>Völler</surname> <given-names>T</given-names></name><name><surname>Minola</surname> <given-names>A</given-names></name><name><surname>Fernandez-Rodriguez</surname> <given-names>B</given-names></name><name><surname>Agatic</surname> <given-names>G</given-names></name><name><surname>Barbieri</surname> <given-names>S</given-names></name><name><surname>Piccoli</surname> <given-names>L</given-names></name><name><surname>Casiraghi</surname> <given-names>C</given-names></name><name><surname>Corti</surname> <given-names>D</given-names></name><name><surname>Lanzavecchia</surname> <given-names>A</given-names></name><name><surname>Regoes</surname> <given-names>RR</given-names></name><name><surname>Loverdo</surname> <given-names>C</given-names></name><name><surname>Stocker</surname> <given-names>R</given-names></name><name><surname>Brumley</surname> <given-names>DR</given-names></name><name><surname>Hardt</surname> <given-names>WD</given-names></name><name><surname>Slack</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>High-avidity IgA protects the intestine by enchaining growing Bacteria</article-title><source>Nature</source><volume>544</volume><fpage>498</fpage><lpage>502</lpage><pub-id pub-id-type="doi">10.1038/nature22058</pub-id><pub-id pub-id-type="pmid">28405025</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olson</surname> <given-names>MV</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>When less is more: gene loss as an engine of evolutionary change</article-title><source>The American Journal of Human Genetics</source><volume>64</volume><fpage>18</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1086/302219</pub-id><pub-id pub-id-type="pmid">9915938</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palm</surname> <given-names>NW</given-names></name><name><surname>de Zoete</surname> <given-names>MR</given-names></name><name><surname>Cullen</surname> <given-names>TW</given-names></name><name><surname>Barry</surname> <given-names>NA</given-names></name><name><surname>Stefanowski</surname> <given-names>J</given-names></name><name><surname>Hao</surname> <given-names>L</given-names></name><name><surname>Degnan</surname> <given-names>PH</given-names></name><name><surname>Hu</surname> <given-names>J</given-names></name><name><surname>Peter</surname> <given-names>I</given-names></name><name><surname>Zhang</surname> <given-names>W</given-names></name><name><surname>Ruggiero</surname> <given-names>E</given-names></name><name><surname>Cho</surname> <given-names>JH</given-names></name><name><surname>Goodman</surname> <given-names>AL</given-names></name><name><surname>Flavell</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Immunoglobulin A coating identifies colitogenic Bacteria in inflammatory bowel disease</article-title><source>Cell</source><volume>158</volume><fpage>1000</fpage><lpage>1010</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2014.08.006</pub-id><pub-id pub-id-type="pmid">25171403</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peterson</surname> <given-names>DA</given-names></name><name><surname>McNulty</surname> <given-names>NP</given-names></name><name><surname>Guruge</surname> <given-names>JL</given-names></name><name><surname>Gordon</surname> <given-names>JI</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>IgA response to symbiotic Bacteria as a mediator of gut homeostasis</article-title><source>Cell Host &amp; Microbe</source><volume>2</volume><fpage>328</fpage><lpage>339</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2007.09.013</pub-id><pub-id pub-id-type="pmid">18005754</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pickard</surname> <given-names>JM</given-names></name><name><surname>Maurice</surname> <given-names>CF</given-names></name><name><surname>Kinnebrew</surname> <given-names>MA</given-names></name><name><surname>Abt</surname> <given-names>MC</given-names></name><name><surname>Schenten</surname> <given-names>D</given-names></name><name><surname>Golovkina</surname> <given-names>TV</given-names></name><name><surname>Bogatyrev</surname> <given-names>SR</given-names></name><name><surname>Ismagilov</surname> <given-names>RF</given-names></name><name><surname>Pamer</surname> <given-names>EG</given-names></name><name><surname>Turnbaugh</surname> <given-names>PJ</given-names></name><name><surname>Chervonsky</surname> <given-names>AV</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Rapid fucosylation of intestinal epithelium sustains host-commensal symbiosis in sickness</article-title><source>Nature</source><volume>514</volume><fpage>638</fpage><lpage>641</lpage><pub-id pub-id-type="doi">10.1038/nature13823</pub-id><pub-id pub-id-type="pmid">25274297</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Råberg</surname> <given-names>L</given-names></name><name><surname>Sim</surname> <given-names>D</given-names></name><name><surname>Read</surname> <given-names>AF</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Disentangling genetic variation for resistance and tolerance to infectious diseases in animals</article-title><source>Science</source><volume>318</volume><fpage>812</fpage><lpage>814</lpage><pub-id pub-id-type="doi">10.1126/science.1148526</pub-id><pub-id pub-id-type="pmid">17975068</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Repik</surname> <given-names>PM</given-names></name><name><surname>Strizki</surname> <given-names>JM</given-names></name><name><surname>Galili</surname> <given-names>U</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Differential host-dependent expression of alpha-galactosyl epitopes on viral glycoproteins: a study of eastern equine encephalitis virus as a model</article-title><source>Journal of General Virology</source><volume>75</volume><fpage>1177</fpage><lpage>1181</lpage><pub-id pub-id-type="doi">10.1099/0022-1317-75-5-1177</pub-id><pub-id pub-id-type="pmid">7513744</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rudd</surname> <given-names>KE</given-names></name><name><surname>Johnson</surname> <given-names>SC</given-names></name><name><surname>Agesa</surname> <given-names>KM</given-names></name><name><surname>Shackelford</surname> <given-names>KA</given-names></name><name><surname>Tsoi</surname> <given-names>D</given-names></name><name><surname>Kievlan</surname> <given-names>DR</given-names></name><name><surname>Colombara</surname> <given-names>DV</given-names></name><name><surname>Ikuta</surname> <given-names>KS</given-names></name><name><surname>Kissoon</surname> <given-names>N</given-names></name><name><surname>Finfer</surname> <given-names>S</given-names></name><name><surname>Fleischmann-Struzek</surname> <given-names>C</given-names></name><name><surname>Machado</surname> <given-names>FR</given-names></name><name><surname>Reinhart</surname> <given-names>KK</given-names></name><name><surname>Rowan</surname> <given-names>K</given-names></name><name><surname>Seymour</surname> <given-names>CW</given-names></name><name><surname>Watson</surname> <given-names>RS</given-names></name><name><surname>West</surname> <given-names>TE</given-names></name><name><surname>Marinho</surname> <given-names>F</given-names></name><name><surname>Hay</surname> <given-names>SI</given-names></name><name><surname>Lozano</surname> <given-names>R</given-names></name><name><surname>Lopez</surname> <given-names>AD</given-names></name><name><surname>Angus</surname> <given-names>DC</given-names></name><name><surname>Murray</surname> <given-names>CJL</given-names></name><name><surname>Naghavi</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Global, regional, and national Sepsis incidence and mortality, 1990-2017: analysis for the global burden of disease study</article-title><source>The Lancet</source><volume>395</volume><fpage>200</fpage><lpage>211</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(19)32989-7</pub-id><pub-id pub-id-type="pmid">31954465</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rühlemann</surname> <given-names>MC</given-names></name><name><surname>Hermes</surname> <given-names>BM</given-names></name><name><surname>Bang</surname> <given-names>C</given-names></name><name><surname>Doms</surname> <given-names>S</given-names></name><name><surname>Moitinho-Silva</surname> <given-names>L</given-names></name><name><surname>Thingholm</surname> <given-names>LB</given-names></name><name><surname>Frost</surname> <given-names>F</given-names></name><name><surname>Degenhardt</surname> <given-names>F</given-names></name><name><surname>Wittig</surname> <given-names>M</given-names></name><name><surname>Kässens</surname> <given-names>J</given-names></name><name><surname>Weiss</surname> <given-names>FU</given-names></name><name><surname>Peters</surname> <given-names>A</given-names></name><name><surname>Neuhaus</surname> <given-names>K</given-names></name><name><surname>Völker</surname> <given-names>U</given-names></name><name><surname>Völzke</surname> <given-names>H</given-names></name><name><surname>Homuth</surname> <given-names>G</given-names></name><name><surname>Weiss</surname> <given-names>S</given-names></name><name><surname>Grallert</surname> <given-names>H</given-names></name><name><surname>Laudes</surname> <given-names>M</given-names></name><name><surname>Lieb</surname> <given-names>W</given-names></name><name><surname>Haller</surname> <given-names>D</given-names></name><name><surname>Lerch</surname> <given-names>MM</given-names></name><name><surname>Baines</surname> <given-names>JF</given-names></name><name><surname>Franke</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Genome-wide association study in 8,956 german individuals identifies influence of ABO histo-blood groups on gut microbiome</article-title><source>Nature Genetics</source><volume>53</volume><fpage>147</fpage><lpage>155</lpage><pub-id pub-id-type="doi">10.1038/s41588-020-00747-1</pub-id><pub-id pub-id-type="pmid">33462482</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singer</surname> <given-names>M</given-names></name><name><surname>Deutschman</surname> <given-names>CS</given-names></name><name><surname>Seymour</surname> <given-names>CW</given-names></name><name><surname>Shankar-Hari</surname> <given-names>M</given-names></name><name><surname>Annane</surname> <given-names>D</given-names></name><name><surname>Bauer</surname> <given-names>M</given-names></name><name><surname>Bellomo</surname> <given-names>R</given-names></name><name><surname>Bernard</surname> <given-names>GR</given-names></name><name><surname>Chiche</surname> <given-names>JD</given-names></name><name><surname>Coopersmith</surname> <given-names>CM</given-names></name><name><surname>Hotchkiss</surname> <given-names>RS</given-names></name><name><surname>Levy</surname> <given-names>MM</given-names></name><name><surname>Marshall</surname> <given-names>JC</given-names></name><name><surname>Martin</surname> <given-names>GS</given-names></name><name><surname>Opal</surname> <given-names>SM</given-names></name><name><surname>Rubenfeld</surname> <given-names>GD</given-names></name><name><surname>van der Poll</surname> <given-names>T</given-names></name><name><surname>Vincent</surname> <given-names>JL</given-names></name><name><surname>Angus</surname> <given-names>DC</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The third international consensus definitions for Sepsis and septic shock (Sepsis-3)</article-title><source>Jama</source><volume>315</volume><fpage>801</fpage><lpage>810</lpage><pub-id pub-id-type="doi">10.1001/jama.2016.0287</pub-id><pub-id pub-id-type="pmid">26903338</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname> <given-names>S</given-names></name><name><surname>Thompson</surname> <given-names>JA</given-names></name><name><surname>Yilmaz</surname> <given-names>B</given-names></name><name><surname>Li</surname> <given-names>H</given-names></name><name><surname>Weis</surname> <given-names>S</given-names></name><name><surname>Sobral</surname> <given-names>D</given-names></name><name><surname>Truglio</surname> <given-names>M</given-names></name><name><surname>Aires da Silva</surname> <given-names>F</given-names></name><name><surname>Aguiar</surname> <given-names>S</given-names></name><name><surname>Carlos</surname> <given-names>AR</given-names></name><name><surname>Rebelo</surname> <given-names>S</given-names></name><name><surname>Cardoso</surname> <given-names>S</given-names></name><name><surname>Gjini</surname> <given-names>E</given-names></name><name><surname>Nuñez</surname> <given-names>G</given-names></name><name><surname>Soares</surname> <given-names>MP</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Loss of α-gal during primate evolution enhanced antibody-effector function and resistance to bacterial Sepsis</article-title><source>Cell Host &amp; Microbe</source><volume>29</volume><fpage>347</fpage><lpage>361</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2020.12.017</pub-id><pub-id pub-id-type="pmid">33497603</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soares</surname> <given-names>MP</given-names></name><name><surname>Yilmaz</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Microbiota control of malaria transmission</article-title><source>Trends in Parasitology</source><volume>32</volume><fpage>120</fpage><lpage>130</lpage><pub-id pub-id-type="doi">10.1016/j.pt.2015.11.004</pub-id><pub-id pub-id-type="pmid">26774793</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sonnenburg</surname> <given-names>ED</given-names></name><name><surname>Smits</surname> <given-names>SA</given-names></name><name><surname>Tikhonov</surname> <given-names>M</given-names></name><name><surname>Higginbottom</surname> <given-names>SK</given-names></name><name><surname>Wingreen</surname> <given-names>NS</given-names></name><name><surname>Sonnenburg</surname> <given-names>JL</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Diet-induced extinctions in the gut Microbiota compound over generations</article-title><source>Nature</source><volume>529</volume><fpage>212</fpage><lpage>215</lpage><pub-id pub-id-type="doi">10.1038/nature16504</pub-id><pub-id pub-id-type="pmid">26762459</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spor</surname> <given-names>A</given-names></name><name><surname>Koren</surname> <given-names>O</given-names></name><name><surname>Ley</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Unravelling the effects of the environment and host genotype on the gut microbiome</article-title><source>Nature Reviews Microbiology</source><volume>9</volume><fpage>279</fpage><lpage>290</lpage><pub-id pub-id-type="doi">10.1038/nrmicro2540</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Springer</surname> <given-names>GF</given-names></name><name><surname>Horton</surname> <given-names>RE</given-names></name></person-group><year iso-8601-date="1969">1969</year><article-title>Blood group isoantibody stimulation in man by feeding blood group-active Bacteria</article-title><source>Journal of Clinical Investigation</source><volume>48</volume><fpage>1280</fpage><lpage>1291</lpage><pub-id pub-id-type="doi">10.1172/JCI106094</pub-id><pub-id pub-id-type="pmid">4893685</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Stearns</surname> <given-names>SC</given-names></name><name><surname>Medzhitov</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2015">2015</year><source>Evolutionary Medicine</source><publisher-name>Oxford University Press</publisher-name></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sunderkötter</surname> <given-names>C</given-names></name><name><surname>Nikolic</surname> <given-names>T</given-names></name><name><surname>Dillon</surname> <given-names>MJ</given-names></name><name><surname>Van Rooijen</surname> <given-names>N</given-names></name><name><surname>Stehling</surname> <given-names>M</given-names></name><name><surname>Drevets</surname> <given-names>DA</given-names></name><name><surname>Leenen</surname> <given-names>PJ</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Subpopulations of mouse blood monocytes differ in maturation stage and inflammatory response</article-title><source>The Journal of Immunology</source><volume>172</volume><fpage>4410</fpage><lpage>4417</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.172.7.4410</pub-id><pub-id pub-id-type="pmid">15034056</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takeuchi</surname> <given-names>Y</given-names></name><name><surname>Porter</surname> <given-names>CD</given-names></name><name><surname>Strahan</surname> <given-names>KM</given-names></name><name><surname>Preece</surname> <given-names>AF</given-names></name><name><surname>Gustafsson</surname> <given-names>K</given-names></name><name><surname>Cosset</surname> <given-names>FL</given-names></name><name><surname>Weiss</surname> <given-names>RA</given-names></name><name><surname>Collins</surname> <given-names>MK</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Sensitization of cells and retroviruses to human serum by (alpha 1-3) galactosyltransferase</article-title><source>Nature</source><volume>379</volume><fpage>85</fpage><lpage>88</lpage><pub-id pub-id-type="doi">10.1038/379085a0</pub-id><pub-id pub-id-type="pmid">8538747</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tearle</surname> <given-names>RG</given-names></name><name><surname>Tange</surname> <given-names>MJ</given-names></name><name><surname>Zannettino</surname> <given-names>ZL</given-names></name><name><surname>Katerelos</surname> <given-names>M</given-names></name><name><surname>Shinkel</surname> <given-names>TA</given-names></name><name><surname>Van Denderen</surname> <given-names>BJ</given-names></name><name><surname>Lonie</surname> <given-names>AJ</given-names></name><name><surname>Lyons</surname> <given-names>I</given-names></name><name><surname>Nottle</surname> <given-names>MB</given-names></name><name><surname>Cox</surname> <given-names>T</given-names></name><name><surname>Becker</surname> <given-names>C</given-names></name><name><surname>Peura</surname> <given-names>AM</given-names></name><name><surname>Wigley</surname> <given-names>PL</given-names></name><name><surname>Crawford</surname> <given-names>RJ</given-names></name><name><surname>Robins</surname> <given-names>AJ</given-names></name><name><surname>Pearse</surname> <given-names>MJ</given-names></name><name><surname>d'Apice</surname> <given-names>AJ</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>The alpha-1,3-galactosyltransferase knockout mouse. Implications for xenotransplantation</article-title><source>Transplantation</source><volume>61</volume><fpage>13</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1097/00007890-199601150-00004</pub-id><pub-id pub-id-type="pmid">8560551</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ubeda</surname> <given-names>C</given-names></name><name><surname>Lipuma</surname> <given-names>L</given-names></name><name><surname>Gobourne</surname> <given-names>A</given-names></name><name><surname>Viale</surname> <given-names>A</given-names></name><name><surname>Leiner</surname> <given-names>I</given-names></name><name><surname>Equinda</surname> <given-names>M</given-names></name><name><surname>Khanin</surname> <given-names>R</given-names></name><name><surname>Pamer</surname> <given-names>EG</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Familial transmission rather than defective innate immunity shapes the distinct intestinal Microbiota of TLR-deficient mice</article-title><source>Journal of Experimental Medicine</source><volume>209</volume><fpage>1445</fpage><lpage>1456</lpage><pub-id pub-id-type="doi">10.1084/jem.20120504</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vincent</surname> <given-names>JL</given-names></name><name><surname>Rello</surname> <given-names>J</given-names></name><name><surname>Marshall</surname> <given-names>J</given-names></name><name><surname>Silva</surname> <given-names>E</given-names></name><name><surname>Anzueto</surname> <given-names>A</given-names></name><name><surname>Martin</surname> <given-names>CD</given-names></name><name><surname>Moreno</surname> <given-names>R</given-names></name><name><surname>Lipman</surname> <given-names>J</given-names></name><name><surname>Gomersall</surname> <given-names>C</given-names></name><name><surname>Sakr</surname> <given-names>Y</given-names></name><name><surname>Reinhart</surname> <given-names>K</given-names></name><collab>EPIC II Group of Investigators</collab></person-group><year iso-8601-date="2009">2009</year><article-title>International study of the prevalence and outcomes of infection in intensive care units</article-title><source>Jama</source><volume>302</volume><fpage>2323</fpage><lpage>2329</lpage><pub-id pub-id-type="doi">10.1001/jama.2009.1754</pub-id><pub-id pub-id-type="pmid">19952319</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vonaesch</surname> <given-names>P</given-names></name><name><surname>Anderson</surname> <given-names>M</given-names></name><name><surname>Sansonetti</surname> <given-names>PJ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Pathogens, microbiome and the host: emergence of the ecological koch's postulates</article-title><source>FEMS Microbiology Reviews</source><volume>42</volume><fpage>273</fpage><lpage>292</lpage><pub-id pub-id-type="doi">10.1093/femsre/fuy003</pub-id><pub-id pub-id-type="pmid">29325027</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>X</given-names></name><name><surname>Grus</surname> <given-names>WE</given-names></name><name><surname>Zhang</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Gene losses during human origins</article-title><source>PLOS Biology</source><volume>4</volume><elocation-id>e52</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pbio.0040052</pub-id><pub-id pub-id-type="pmid">16464126</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yilmaz</surname> <given-names>B</given-names></name><name><surname>Portugal</surname> <given-names>S</given-names></name><name><surname>Tran</surname> <given-names>TM</given-names></name><name><surname>Gozzelino</surname> <given-names>R</given-names></name><name><surname>Ramos</surname> <given-names>S</given-names></name><name><surname>Gomes</surname> <given-names>J</given-names></name><name><surname>Regalado</surname> <given-names>A</given-names></name><name><surname>Cowan</surname> <given-names>PJ</given-names></name><name><surname>d'Apice</surname> <given-names>AJ</given-names></name><name><surname>Chong</surname> <given-names>AS</given-names></name><name><surname>Doumbo</surname> <given-names>OK</given-names></name><name><surname>Traore</surname> <given-names>B</given-names></name><name><surname>Crompton</surname> <given-names>PD</given-names></name><name><surname>Silveira</surname> <given-names>H</given-names></name><name><surname>Soares</surname> <given-names>MP</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Gut Microbiota elicits a protective immune response against malaria transmission</article-title><source>Cell</source><volume>159</volume><fpage>1277</fpage><lpage>1289</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2014.10.053</pub-id><pub-id pub-id-type="pmid">25480293</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeng</surname> <given-names>MY</given-names></name><name><surname>Cisalpino</surname> <given-names>D</given-names></name><name><surname>Varadarajan</surname> <given-names>S</given-names></name><name><surname>Hellman</surname> <given-names>J</given-names></name><name><surname>Warren</surname> <given-names>HS</given-names></name><name><surname>Cascalho</surname> <given-names>M</given-names></name><name><surname>Inohara</surname> <given-names>N</given-names></name><name><surname>Núñez</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Gut Microbiota-Induced immunoglobulin G controls systemic infection by symbiotic Bacteria and pathogens</article-title><source>Immunity</source><volume>44</volume><fpage>647</fpage><lpage>658</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2016.02.006</pub-id><pub-id pub-id-type="pmid">26944199</pub-id></element-citation></ref></ref-list><app-group><app id="appendix-1"><title>Appendix 1</title><boxed-text><table-wrap id="keyresource" position="anchor"><label>Appendix 1—key resources table</label><table frame="hsides" rules="groups"><thead><tr><th>Reagent type (species) or resource</th><th>Designation</th><th>Source or reference</th><th>Identifiers</th><th>Additional information</th></tr></thead><tbody><tr><td>Strain, strain background (<italic>Mus musculus</italic>)</td><td>B6.C57BL/6/J: <italic>Ggta1<sup>+/+</sup></italic></td><td>Obtained originally from Jackson Laboratory and maintained at IGC</td><td>N/A</td><td/></tr><tr><td>Strain, strain background (<italic>Mus musculus</italic>)</td><td>B6. <italic>Ggta1<sup>-/-</sup></italic></td><td>Obtained originally from <xref ref-type="bibr" rid="bib68">Tearle et al., 1996</xref> and maintained at IGC</td><td>N/A</td><td/></tr><tr><td>Strain, strain background (<italic>Mus musculus</italic>)</td><td>B6. <italic>Igha<sup>-/-</sup>Ggta1<sup>-/-</sup></italic></td><td><xref ref-type="bibr" rid="bib60">Singh et al., 2021</xref></td><td>N/A</td><td/></tr><tr><td>Strain, strain background (<italic>Mus musculus</italic>)</td><td>B6. <italic>Igh-J<sup>-/-</sup>Ggta1<sup>-/-</sup></italic></td><td><xref ref-type="bibr" rid="bib73">Yilmaz et al., 2014</xref></td><td>N/A</td><td/></tr><tr><td>Strain, strain background (<italic>Mus musculus</italic>)</td><td>B6. <italic>Rag2<sup>-/-</sup>Ggta1<sup>-/-</sup></italic></td><td><xref ref-type="bibr" rid="bib60">Singh et al., 2021</xref></td><td>N/A</td><td/></tr><tr><td>Strain, strain background (<italic>Mus musculus</italic>)</td><td>B6. <italic>Tcrb<sup>-/-</sup>Ggta1<sup>-/-</sup></italic></td><td><xref ref-type="bibr" rid="bib73">Yilmaz et al., 2014</xref></td><td>N/A</td><td/></tr><tr><td>Strain, strain background (<italic>Bifidobacterium bifidum</italic>)</td><td><italic>Bifidobacterium bifidum</italic> BB-G90</td><td>BioGrowing Probiotics</td><td>N/A</td><td>See Materials and methods, Section Detection of αGal expression by probiotic bacteria</td></tr><tr><td>Strain, strain background (<italic>Bifidobacterium breve</italic>)</td><td><italic>Bifidobacterium breve</italic> BB-G95</td><td>BioGrowing Probiotics</td><td>N/A</td><td>See Materials and methods, Section Detection of αGal expression by probiotic bacteria</td></tr><tr><td>Strain, strain background (<italic>Bifidobacterium infantis</italic>)</td><td><italic>Bifidobacterium infantis</italic> BI-G191</td><td>BioGrowing Probiotics</td><td>N/A</td><td>See Materials and methods, Section Detection of αGal expression by probiotic bacteria</td></tr><tr><td>Strain, strain background (<italic>Bifidobacterium infantis</italic>)</td><td><italic>Bifidobacterium infantis</italic> BI-G201</td><td>BioGrowing Probiotics</td><td>N/A</td><td>See Materials and methods, Section Detection of αGal expression by probiotic bacteria</td></tr><tr><td>Strain, strain background (<italic>Bifidobacterium lactis</italic>)</td><td><italic>Bifidobacterium lactis</italic> BL-G101</td><td>BioGrowing Probiotics</td><td>N/A</td><td>See Materials and methods, Section Detection of αGal expression by probiotic bacteria</td></tr><tr><td>Strain, strain background (<italic>Bifidobacterium longum</italic>)</td><td><italic>Bifidobacterium longum</italic> BL-G301</td><td>BioGrowing Probiotics</td><td>N/A</td><td>See Materials and methods, Section Detection of αGal expression by probiotic bacteria</td></tr><tr><td>Strain, strain background (<italic>Escherichia coli</italic>)</td><td><italic>Escherichia coli</italic> K12</td><td>ATCC</td><td>ATCC10798</td><td>See Materials and methods, Section Detection of αGal expression by probiotic bacteria</td></tr><tr><td>Strain, strain background (<italic>Escherichia coli</italic>)</td><td><italic>Escherichia coli</italic> O86:B7</td><td>ATCC</td><td>ATCC12701</td><td>See Materials and methods, Section Detection of αGal expression by probiotic bacteria</td></tr><tr><td>Strain, strain background (<italic>Lactobacillus acidophilus</italic>)</td><td><italic>Lactobacillus acidophilus</italic> LA-G80</td><td>BioGrowing Probiotics</td><td>N/A</td><td>See Materials and methods, Section Detection of αGal expression by probiotic bacteria</td></tr><tr><td>Strain, strain background (<italic>Lactobacillus acidophilus</italic>)</td><td><italic>Lactobacillus acidophilus</italic> LA-G436</td><td>BioGrowing Probiotics</td><td>N/A</td><td>See Materials and methods, Section Detection of αGal expression by probiotic bacteria</td></tr><tr><td>Strain, strain background (<italic>Lactobacillus bulgaricus</italic>)</td><td><italic>Lactobacillus bulgaricus</italic> LB-G4058</td><td>BioGrowing Probiotics</td><td>N/A</td><td>See Materials and methods, Section Detection of αGal expression by probiotic bacteria</td></tr><tr><td>Strain, strain background (<italic>Lactobacillus bulgaricus</italic>)</td><td><italic>Lactobacillus bulgaricus</italic> LB-G117</td><td>BioGrowing Probiotics</td><td>N/A</td><td>See Materials and methods, Section Detection of αGal expression by probiotic bacteria</td></tr><tr><td>Strain, strain background (<italic>Lactobacillus bulgaricus</italic>)</td><td><italic>Lactobacillus bulgaricus</italic> LB-G40</td><td>BioGrowing Probiotics</td><td>N/A</td><td>See Materials and methods, Section Detection of αGal expression by probiotic bacteria</td></tr><tr><td>Strain, strain background (<italic>Lactobacillus casei</italic>)</td><td><italic>Lactobacillus casei</italic> LC-G11</td><td>BioGrowing Probiotics</td><td>N/A</td><td>See Materials and methods, Section Detection of αGal expression by probiotic bacteria</td></tr><tr><td>Strain, strain background (<italic>Lactobacillus cremoris</italic>)</td><td><italic>Lactobacillus cremoris</italic> LLC-G42</td><td>BioGrowing Probiotics</td><td>N/A</td><td>See Materials and methods, Section Detection of αGal expression by probiotic bacteria</td></tr><tr><td>Strain, strain background (<italic>Lactobacillus helveticus</italic>)</td><td><italic>Lactobacillus helveticus</italic> LH-G444</td><td>BioGrowing Probiotics</td><td>N/A</td><td>See Materials and methods, Section Detection of αGal expression by probiotic bacteria</td></tr><tr><td>Strain, strain background (<italic>Lactobacillus casei</italic>)</td><td><italic>Lactobacillus casei</italic> LC-G402</td><td>BioGrowing Probiotics</td><td>N/A</td><td>See Materials and methods, Section Detection of αGal expression by probiotic bacteria</td></tr><tr><td>Strain, strain background (<italic>Lactobacillus lactis</italic>)</td><td><italic>Lactobacillus lactis</italic> LLL-G25</td><td>BioGrowing Probiotics</td><td>N/A</td><td>See Materials and methods, Section Detection of αGal expression by probiotic bacteria</td></tr><tr><td>Strain, strain background (<italic>Lactobacillus plantarum</italic>)</td><td><italic>Lactobacillus plantarum</italic> Lp-G18</td><td>BioGrowing Probiotics</td><td>N/A</td><td>See Materials and methods, Section Detection of αGal expression by probiotic bacteria</td></tr><tr><td>Strain, strain background (<italic>Lactobacillus paracasei</italic>)</td><td><italic>Lactobacillus paracasei</italic> LpC-G110</td><td>BioGrowing Probiotics</td><td>N/A</td><td>See Materials and methods, Section Detection of αGal expression by probiotic bacteria</td></tr><tr><td>Strain, strain background (<italic>Lactobacillus plantarum</italic>)</td><td><italic>Lactobacillus plantarum</italic> Lp-G425</td><td>BioGrowing Probiotics</td><td>N/A</td><td>See Materials and methods, Section Detection of αGal expression by probiotic bacteria</td></tr><tr><td>Strain, strain background (<italic>Lactobacillus plantarum</italic>)</td><td><italic>Lactobacillus plantarum</italic> Lp-G429</td><td>BioGrowing Probiotics</td><td>N/A</td><td>See Materials and methods, Section Detection of αGal expression by probiotic bacteria</td></tr><tr><td>Strain, strain background (<italic>Lactobacillus plantarum</italic>)</td><td><italic>Lactobacillus plantarum</italic> Lp-G443</td><td>BioGrowing Probiotics</td><td>N/A</td><td>See Materials and methods, Section Detection of αGal expression by probiotic bacteria</td></tr><tr><td>Strain, strain background (<italic>Lactobacillus reuteri</italic>)</td><td><italic>Lactobacillus reuteri</italic> Lr-G100</td><td>BioGrowing Probiotics</td><td>N/A</td><td>See Materials and methods, Section Detection of αGal expression by probiotic bacteria</td></tr><tr><td>Strain, strain background (<italic>Lactobacillus rhamnosus</italic>)</td><td><italic>Lactobacillus rhamnosus</italic> Lr-G14</td><td>BioGrowing Probiotics</td><td>N/A</td><td>See Materials and methods, Section Detection of αGal expression by probiotic bacteria</td></tr><tr><td>Strain, strain background (<italic>Lactobacillus rhamnosus</italic>)</td><td><italic>Lactobacillus rhamnosus</italic> Lr-G26</td><td>BioGrowing Probiotics</td><td>N/A</td><td>See Materials and methods, Section Detection of αGal expression by probiotic bacteria</td></tr><tr><td>Strain, strain background (<italic>Lactobacillus salivarus</italic>)</td><td><italic>Lactobacillus salivarus</italic> LS-G60</td><td>BioGrowing Probiotics</td><td>N/A</td><td>See Materials and methods, Section Detection of αGal expression by probiotic bacteria</td></tr><tr><td>Strain, strain background (<italic>Streptococcus thermophilus</italic>)</td><td><italic>Streptococcus thermophilus</italic> ST-G30</td><td>BioGrowing Probiotics</td><td>N/A</td><td>See Materials and methods, Section Detection of αGal expression by probiotic bacteria</td></tr><tr><td>Antibody</td><td>Anti-Mouse Monoclonal Gr1 (Clone: RB6-8C5)</td><td>Bio-Rad</td><td>N/A</td><td>300 µg in 200 µL PBS per mouse</td></tr><tr><td>Antibody</td><td>Anti-Mouse Monoclonal IgA (mA-6E1)</td><td>eBioscience, Thermo Fisher Scientific</td><td>Cat# 12-4204-82, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_465917">AB_465917</ext-link></td><td>1:100 (Flow cytometry)</td></tr><tr><td>Antibody</td><td>Goat Anti-Mouse Polyclonal IgA-HRP</td><td>Southern Biotech</td><td>Cat# 1040–05; <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2714213">AB_2714213</ext-link></td><td>1:4000 (ELISA)</td></tr><tr><td>Antibody</td><td>Goat Anti-Mouse Polyclonal IgA-Unlabelled</td><td>Southern Biotech</td><td>Cat# 1040–01, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2314669">AB_2314669</ext-link></td><td>2 µg/mL (ELISA)</td></tr><tr><td>Antibody</td><td>Goat Anti-Mouse Polyclonal IgG, Human ads-HRP</td><td>Southern Biotech</td><td>Cat# 1030–05, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2619742">AB_2619742</ext-link></td><td>1:4000 (ELISA)</td></tr><tr><td>Antibody</td><td>Goat Anti-Mouse Polyclonal IgM, Human ads-HRP</td><td>Southern Biotech</td><td>Cat# 1020–05, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2794201">AB_2794201</ext-link></td><td>1:4000 (ELISA)</td></tr><tr><td>Antibody</td><td>Anti-α-gal Mouse Monoclonal IgG1</td><td><xref ref-type="bibr" rid="bib16">Ding et al., 2008</xref>; <xref ref-type="bibr" rid="bib73">Yilmaz et al., 2014</xref></td><td>N/A</td><td>Standard (ELISA). 0,5 μg/mL, 1:2 serial dilutions, 50 μL</td></tr><tr><td>Antibody</td><td>Anti-α-gal Mouse Monoclonal IgG2a</td><td><xref ref-type="bibr" rid="bib73">Yilmaz et al., 2014</xref></td><td>N/A</td><td>Standard (ELISA). 0,5 Originally o/mL, 1:3 serial dilutions, 50 μL</td></tr><tr><td>Antibody</td><td>Anti-α-gal Mouse Monoclonal IgG2b</td><td><xref ref-type="bibr" rid="bib16">Ding et al., 2008</xref>; <xref ref-type="bibr" rid="bib73">Yilmaz et al., 2014</xref></td><td>N/A</td><td>Standard (ELISA). 0,5 μg/mL, 1:3 serial dilutions, 50 μL</td></tr><tr><td>Antibody</td><td>Anti-α-gal Mouse Monoclonal IgG3</td><td><xref ref-type="bibr" rid="bib16">Ding et al., 2008</xref>; <xref ref-type="bibr" rid="bib73">Yilmaz et al., 2014</xref></td><td>N/A</td><td>Standard (ELISA). 0,5 μg/mL, 1:2 serial dilution</td></tr><tr><td>Antibody</td><td>Anti-α-gal Mouse Monoclonal IgM</td><td><xref ref-type="bibr" rid="bib73">Yilmaz et al., 2014</xref></td><td>N/A</td><td>Standard (ELISA). 2 μg/mL, 1:2 serial dilutions, 50 μL</td></tr><tr><td>Antibody</td><td>Mouse IgA-Unlabelled</td><td>Southern Biotech</td><td>Cat# 0106–01, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2714214">AB_2714214</ext-link></td><td>Standard 0.5 µg/mL(ELISA)</td></tr><tr><td>Commercial assay or kit</td><td>KAPA Mouse Genotyping Kit</td><td>KAPA Biosystems</td><td>Cat# KK7352</td><td/></tr><tr><td>Commercial assay or kit</td><td>LEGEND MAX Mouse NGAL (Lipocalin-2) ELISA Kit</td><td>Biolegend</td><td>Cat# 443707</td><td/></tr><tr><td>Commercial assay or kit</td><td>QIAamp Fast DNA Stool Mini Kit</td><td>Qiagen</td><td>Cat# 50951604</td><td/></tr><tr><td>Chemical compound, drμg</td><td>Clodronate liposomes and control liposomes (PBS)</td><td><ext-link ext-link-type="uri" xlink:href="https://clodronateliposomes.com/">https://clodronateliposomes.com/</ext-link></td><td>SKU: CP-005–005</td><td>10 µL/g (in vivo depletion)</td></tr><tr><td>Chemical compound, drμg</td><td>Galα1-3Galβ1-4GlcNAc-BSA (14 atom spacer)</td><td>Dextra</td><td>Cat# NGP1334</td><td>5 µg/mL (ELISA)</td></tr><tr><td>Chemical compound, drμg</td><td>Lectin from Bandeiraea simplicifolia (Griffonia simplicifolia) Isolectin B4 (BSI-B4), FITC conjμgate, lyophilized powder</td><td>Sigma-Aldrich</td><td>#L2895-1MG</td><td>40 µg/mL (Flow cytometry)</td></tr><tr><td>Chemical compound, drμg</td><td>SYTO41 Blue Fluorescent Nucleic Acid Stain</td><td>Thermofisher Scientific</td><td>Cat# S11352</td><td>1:200 (Flow cytometry)</td></tr><tr><td>Software, algorithm</td><td>Greengenes</td><td><xref ref-type="bibr" rid="bib14">DeSantis et al., 2006</xref></td><td><ext-link ext-link-type="uri" xlink:href="http://greengenes.secondgenome.com/v0.13.8">http://greengenes.secondgenome.com/v0.13.8</ext-link></td><td/></tr><tr><td>Software, algorithm</td><td>QIIME</td><td><xref ref-type="bibr" rid="bib8">Caporaso et al., 2010</xref></td><td><ext-link ext-link-type="uri" xlink:href="http://qiime.org/v0.1.9.1">http://qiime.org/v0.1.9.1</ext-link></td><td/></tr></tbody></table></table-wrap></boxed-text></app></app-group></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.67450.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Turnbaugh</surname><given-names>Peter</given-names></name><role>Reviewing Editor</role><aff><institution>University of California, San Francisco</institution><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Gagneux</surname><given-names>Pascal</given-names> </name><role>Reviewer</role><aff><institution>UCSD</institution><country>United States</country></aff></contrib><contrib contrib-type="reviewer"><name><surname>Medzhitov</surname><given-names>Ruslan</given-names> </name><role>Reviewer</role><aff><institution/></aff></contrib><contrib contrib-type="reviewer"><name><surname>Barreiro</surname><given-names>Luis B</given-names></name><role>Reviewer</role><aff><institution>University of Montreal</institution><country>Canada</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>Our editorial process produces two outputs: i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2021.02.10.430443">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2021.02.10.430443v1.full">the preprint</ext-link> for the benefit of readers; ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Acceptance summary:</bold></p><p>30 million years ago the ancestors of Old World primates lost the ability to produce α-gal due to the fixation of several loss-of-function mutations in the <italic>GGTA1</italic> gene. The evolutionary advantage of such a loss remains elusive. Here, the authors provide additional insights into the pleiotropic role of <italic>Ggta1</italic> in shaping the gut microbiota, immune function, susceptibility to sepsis, and eventual fitness advantage.</p><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Glycan-Based shaping of the Microbiota during Primate Evolution&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 3 peer reviewers, and the evaluation has been overseen by a Reviewing Editor and George Perry as the Senior Editor. The following individuals involved in review of your submission have agreed to reveal their identity: Pascale Gagneux (Reviewer #1); Ruslan Medzhitov (Reviewer #2); Luis B Barreiro (Reviewer #3).</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions:</p><p>1. Please see the recommendations for authors for additional points of clarity. You're welcome to include additional data but textual edits are probably sufficient.</p><p>2. Please also address the following additional points: How do you reconcile the fact that despite not expressing a-gal, apes and OWM are much more susceptible to sepsis as compared to species that do express a-gal, such as mice? In the context of increased resistance to sepsis what seems to be more important – the remodeling of the microbiome by IgA or the increased effector function of IgG? The fact that the microbiome of laboratory mice and primates is likely very different and therefore further experiments are needed to evaluate if the findings described in this work directly translate to a mechanisms of increased resistant to sepsis in primates. Please discuss the potential ramifications of IgG glycosylation changes and after α Gal loss. Given the demonstrated role of sialylation for effector function of IgG, could it be that lack of α Gal actually leads to higher levels of terminal sialic acid on IcG Fc N-glycans, and what would be the functional effects of that?</p><p><italic>Reviewer #1 (Recommendations for the authors):</italic></p><p>CMAH/ Cmah loss-of function occurred at least 8 times concergently across mammals: Human, New-World monkey, Mustelids, twice in microbats, white tailed deer, sperm whale, and hedgehogs (Springer et al. 2014, PMID: 25124893, Ng et al. 2014 PMID: 25517696, Peri et al. 2018 PMID:29206915).</p><p>In stark contrast to α Gal, no microbe has yet been documented to be decorated with intrinsic N-glycolyl neuramninic acid, so microbiome immunization is very unlikely in that contsetx, although some human pathobionts, e.g. Hemophilus may accumulate it from the human host, where dietary Neu5Gc can become incorporated in human glycoconjugates.</p><p>The use of Bandeiraea simplicifolia plant lectin (BSL-B4) for staining of α Gal glycan epitopes is well established. Nevertheless, using a negative control, such as treatment with coffee bean galactosidase specifically acting on terminal α 1,3 Galactose to confirm the α-Gal epitopes on various microbes might be very useful.</p><p>The authors propose that the lack of GGTA in humans and other primates of Africa and Asia might have helped mitigate sepsis pathology, but they should address the well-known observation that humans are much more prone to sepsis than other mammals, <italic>including</italic> Old World monkeys and apes.</p><p>Many unusual things have happened to immunity on the lineage leading to modern humans. Could the authors discuss any evidence that other Old World Primates are somehow less prone to sepsis than α Gal positive mammas, including their New World primate cousins?</p><p>Page 2 Line 72 IgA limits, not limit.</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>I think the authors did a great job at investigating the consequences of GGTA deletion and its impact on host -microbiome interactions. I think the study can be accepted pretty much 'as is'.</p><p><italic>Reviewer #3 (Recommendations for the authors):</italic></p><p>One major open question is how much of the phenotypes described herein are representative of what happens in primates once they lost GGTA1 (which is ultimately what motivated the work ). Although I appreciate that similar experiments cannot be performed in primates there are a few experiments that would be doable. For example, the authors could analyze microbiome data from New- vs Old-world primates (humans included) to see if the former (who still express a-gal) do indeed have a less pathogenic microbiome (there is data out there already available). Another experiment would be to perform the sepsis challenges using cecal inoculum derived from New- vs Old-world primates/humans and see if the microbiome from New world monkeys is indeed less pathogenic than that from Old-world primates, as predicted by their model. In the absence of doing such experiments the authors should at least discuss the fact that what they are seeing in mice might not be reflective of what happens in primates, especially given the fact that the microbiome is mostly shaped by environmental factors that are dramatically different between primates and rodents.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.67450.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1. Please see the recommendations for authors for additional points of clarity. You're welcome to include additional data but textual edits are probably sufficient.</p><p>2. Please also address the following additional points: How do you reconcile the fact that despite not expressing a-gal, apes and OWM are much more susceptible to sepsis as compared to species that do express a-gal, such as mice?</p></disp-quote><p>In response to this comment the following paragraph was added to the manuscript´s <italic>Discussion:</italic></p><p>“When challenged experimentally with a bacterial inoculum or bacterial lipopolysaccharide (LPS), non-human primates appear to be far more susceptible to develop sepsis or septic shock, respectively, as compared to other mammalian lineages (Chen et al., 2019). […] This interpretation is consistent with resistance and disease tolerance to infection being negatively correlated (Raberg et al., 2007), such that traits increasing resistance might be associated with a reduction in disease tolerance, as an evolutionary trade-off.”</p><disp-quote content-type="editor-comment"><p>In the context of increased resistance to sepsis what seems to be more important – the remodeling of the microbiome by IgA or the increased effector function of IgG?</p></disp-quote><p>Our manuscript provides experimental evidence to suggest that antibodies targeting bacteria in the gut microbiota shape the microbiota composition of <italic>Ggta1</italic>-deficient mice in a manner that is distinct from antibodies generated by wild type mice. In doing so, antibodies generated by <italic>Ggta1</italic>-deficient mice reduce the microbiome pathogenicity, as assessed by development of lethal forms of sepsis upon systemic infection by microbiota inoculum. While the mechanism underlying microbiota shaping is antibody-dependent, the effector mechanism enhancing resistance against the shaped microbiota acts irrespectively of antibodies. We added the following paragraph to the manuscript's <italic>Discussion</italic> to highlight this point:</p><p>“We propose that <italic>Ggta1</italic> deletion in mice increases resistance to bacterial sepsis via two distinct antibody-dependent mechanisms. […] It is possible however, that similar to IgG(Singh et al., 2021), the absence of αGal from the glycan structures of different Ig isotypes, including IgA, modulates their effector function, when targeting immunogenic bacteria in the microbiota.“</p><disp-quote content-type="editor-comment"><p>The fact that the microbiome of laboratory mice and primates is likely very different and therefore further experiments are needed to evaluate if the findings described in this work directly translate to a mechanisms of increased resistant to sepsis in primates.</p></disp-quote><p>We addressed this comment by editing the Discussion section, as follows:</p><p>“While our studies do not provide direct evidence that the loss of αGal played a major role in shaping the microbiota composition of Old- <italic>vs.</italic> New World primates this notion is supported, indirectly, by the recent finding that mutations altering the expression of human ABO blood group glycans are associated with shaping of the bacterial composition of the gut microbiota (Rühlemann et al., 2021). […] Whether or not this is the case, considering that microbiota composition is shaped mostly by environmental factors, remains to be formally established.”</p><disp-quote content-type="editor-comment"><p>Please discuss the potential ramifications of IgG glycosylation changes and after α Gal loss. Given the demonstrated role of sialylation for effector function of IgG, could it be that lack of α Gal actually leads to higher levels of terminal sialic acid on IcG Fc N-glycans, and what would be the functional effects of that?</p></disp-quote><p>IgG carry biantennary glycan structures, N-linked to the Fc domain on an evolutionarily conserved asparagine (N297). These glycan structures contain varying amounts of N-acetylglucosamine, mannose, fucose, galactose and terminal sialic acids (Neu5Gc or Neu5Ac), which are linked to galactose (Cobb, 2019). When present in these glycan structures, αGal residues can modulate IgG-Fcγ binding and IgG effector function, as demonstrated in mice (Singh et al., 2021). This suggests that the loss <italic>GGTA1</italic> function during primate evolution might have exerted a similar effect on the human IgG effector function. Humans carry in addition, a non-functional CMP-N-acetylneuraminic acid hydroxylase (<italic>CMAH</italic>) gene and as such fail to produce terminal N-glycolylneuraminic acid (Neu5Gc) residues. Instead, human IgG-associated glycan strictures express terminal N-acetylneuraminic acid (Neu5Ac) residues, lacking the oxygen atom added by CMAH on the Neu5Gc residue. Terminal Neu5Ac residues in the biantennary glycan structures of IgG are linked to galactose and exert a major effect on IgG effector function (Cobb, 2019). Presumably, the combined evolutionary loss of terminal αGal and Neu5Gc residues from the biantennary glycan structures of human IgG is a defining feature of human IgG effector function. This remains however, to be formally established.</p><disp-quote content-type="editor-comment"><p>Reviewer #1 (Recommendations for the authors):</p><p>CMAH/ Cmah loss-of function occurred at least 8 times concergently across mammals: Human, New-World monkey, Mustelids, twice in microbats, white tailed deer, sperm whale, and hedgehogs (Springer et al. 2014, PMID: 25124893, Ng et al. 2014 PMID: 25517696, Peri et al. 2018 PMID:29206915).</p></disp-quote><p>While natural selection and fixation of <italic>GGTA1</italic> loss-of-function mutations is a rare event, it probably occurred several times in non-mammalian vertebrates, as suggested by the apparent lack of αGal expression in cells isolated from fish, frogs, quails, ducks or chickens (Galili et al., 1988). While it is assumed that natural selection and fixation of <italic>GGTA1</italic> loss-of-function mutations has not occurred in mammals, perhaps other than Old-World primates, this remains to the best of our knowledge, to be formally established.</p><disp-quote content-type="editor-comment"><p>In stark contrast to α Gal, no microbe has yet been documented to be decorated with intrinsic N-glycolyl neuramninic acid, so microbiome immunization is very unlikely in that contsetx, although some human pathobionts, e.g. Hemophilus may accumulate it from the human host, where dietary Neu5Gc can become incorporated in human glycoconjugates.</p></disp-quote><p>Preformed αGal-specific antibodies are protective against zoonotic diseases caused by blood borne pathogens expressing αGal-like glycans, including membrane-enveloped viruses (Takeuchi et al., 1996), bacteria (Hamadeh et al., 1992) and protozoan parasites(Soares and Yilmaz, 2016; Yilmaz et al., 2014). This suggests that natural selection of <italic>GGTA1</italic> loss-of-function mutations was propelled by the emergence of protective immunity targeting pathogens expressing αGal-like glycans. The apparent absence of N-glycolylneuraminic acid expression in microbes would suggest that the process of natural selection of <italic>CMAH</italic> loss-of-function mutations was not propelled by the emergence of protective immunity against pathogens expressing this glycan. An alternative interpretation however, would be that loss of <italic>CMAH</italic> function and the emergence of antibodies directed against N-glycolylneuraminic acid might confer protective immunity against zoonotic membrane-enveloped viruses. In support of this notion, enveloped viruses can carry host cell derived glycans, suggesting that antibodies directed against N-glycolylneuraminic acid might act as an immediate resistance mechanism against zoonotic transmission from primates carrying a functional <italic>CMAH</italic> to humans carrying a non-functional <italic>CMAH</italic>. This hypothesis remains however, to the formally tested.</p><disp-quote content-type="editor-comment"><p>The use of Bandeiraea simplicifolia plant lectin (BSL-B4) for staining of α Gal glycan epitopes is well established. Nevertheless, using a negative control, such as treatment with coffee bean galactosidase specifically acting on terminal α 1,3 Galactose to confirm the α-Gal epitopes on various microbes might be very useful.</p></disp-quote><p>This is indeed a standard control for the specificity of the α-gal detection. We have not performed these experiments for logistic reasons.</p><disp-quote content-type="editor-comment"><p>The authors propose that the lack of GGTA in humans and other primates of Africa and Asia might have helped mitigate sepsis pathology, but they should address the well-known observation that humans are much more prone to sepsis than other mammals, INCLUDING Old World monkeys and apes.</p><p>Many unusual things have happened to immunity on the lineage leading to modern humans. Could the authors discuss any evidence that other Old World Primates are somehow less prone to sepsis than α Gal positive mammas, including their New World primate cousins?</p></disp-quote><p>This is indeed an important point towards the validation of our findings in mice towards a better understanding of primate immunity and evolution. We are not aware of experimental evidence comparing the susceptibility to sepsis in Old <italic>vs.</italic> New World Primates. In response to this comment (also raised by Reviewer 3) we introduced the following paragraph in the Discussion section. Of note, we had previously discussed this specific point (Singh et al., 2021) and have done so here in a manner that is, we believe, non-redundant.</p><p>“When challenged experimentally with a bacterial inoculum or bacterial lipopolysaccharide (LPS), non-human primates appear to be far more susceptible to develop sepsis or septic shock, respectively, as compared to other mammalian lineages (Chen et al., 2019). […] This interpretation is consistent with resistance and disease tolerance to infection being negatively correlated (Raberg et al., 2007), such that traits increasing resistance might be associated with a reduction in disease tolerance, as an evolutionary trade-off.”</p><disp-quote content-type="editor-comment"><p>Page 2 Line 72 IgA limits, not limit.</p></disp-quote><p>This was corrected, thank you for pointing it out.</p><disp-quote content-type="editor-comment"><p>Reviewer #3 (Recommendations for the authors):</p><p>One major open question is how much of the phenotypes described herein are representative of what happens in primates once they lost GGTA1 (which is ultimately what motivated the work ). Although I appreciate that similar experiments cannot be performed in primates there are a few experiments that would be doable. For example, the authors could analyze microbiome data from New- vs Old-world primates (humans included) to see if the former (who still express a-gal) do indeed have a less pathogenic microbiome (there is data out there already available). Another experiment would be to perform the sepsis challenges using cecal inoculum derived from New- vs Old-world primates/humans and see if the microbiome from New world monkeys is indeed less pathogenic than that from Old-world primates, as predicted by their model. In the absence of doing such experiments the authors should at least discuss the fact that what they are seeing in mice might not be reflective of what happens in primates, especially given the fact that the microbiome is mostly shaped by environmental factors that are dramatically different between primates and rodents.</p></disp-quote><p>We agree with this comment and have addressed it, as suggested, by editing the Discussion section, as follows:</p><p>“While our studies do not provide direct evidence that the loss of αGal played a major role in shaping the microbiota composition of Old- <italic>vs.</italic> New World primates this notion is supported, indirectly, by the recent finding that mutations altering the expression of human ABO blood group glycans are associated with shaping of the bacterial composition of the gut microbiota (Rühlemann et al., 2021). […] Whether or not this is the case, considering that microbiota composition is shaped mostly by environmental factors, remains to be formally established.”</p><p>References:</p><p>Ayres, J.S. (2016). Cooperative Microbial Tolerance Behaviors in Host-Microbiota Mutualism. Cell 165, 1323-1331.</p><p>Chen, L., Welty-Wolf, K.E., and Kraft, B.D. (2019). Nonhuman primate species as models of human bacterial sepsis. Lab Anim (NY) 48, 57-65.</p><p>Cobb, B.A. (2019). The history of IgG glycosylation and where we are now. Glycobiology 30, 202-213.</p><p>Galili, U., Shohet, S.B., Kobrin, E., Stults, C.L., and Macher, B.A. (1988). Man, apes, and Old World monkeys differ from other mammals in the expression of α-galactosyl epitopes on nucleated cells. J Biol Chem 263, 17755-17762.</p><p>Hamadeh, R.M., Jarvis, G.A., Galili, U., Mandrell, R.E., Zhou, P., and Griffiss, J.M. (1992). Human natural anti-Gal IgG regulates alternative complement pathway activation on bacterial surfaces. J Clin Invest 89, 1223-1235.</p><p>Martins, R., Carlos, A.R., Braza, F., Thompson, J.A., Bastos-Amador, P., Ramos, S., and Soares, M.P. (2019). Disease Tolerance as an Inherent Component of Immunity. Annual Reviews of Immunology 37.</p><p>Medzhitov, R., Schneider, D., and Soares, M. (2012). Disease Tolerance as a Defense Strategy. Science 335, 936-941.</p><p>Olson, M.V. (1999). When less is more: gene loss as an engine of evolutionary change. Am J Hum Genet 64, 18-23.</p><p>Raberg, L., Sim, D., and Read, A.F. (2007). Disentangling genetic variation for resistance and tolerance to infectious diseases in animals. Science 318, 812-814.</p><p>Rühlemann, M.C., Hermes, B.M., Bang, C., Doms, S., Moitinho-Silva, L., Thingholm, L.B., Frost, F., Degenhardt, F., Wittig, M., Kässens, J., et al. (2021). Genome-wide association study in 8,956 German individuals identifies influence of ABO histo-blood groups on gut microbiome. Nature Genetics 53, 147-155.</p><p>Singh, S., Thompson, J.A., Yilmaz, B., Li, H., Weis, S., Sobral, D., Truglio, M., Aires da Silva, F., Aguiar, S., Carlos, A.R., et al. (2021). Loss of α-gal during primate evolution enhanced antibody-effector function and resistance to bacterial sepsis. Cell Host Microbe 29, 347-361.e312.</p><p>Soares, M.P., and Yilmaz, B. (2016). Microbiota Control of Malaria Transmission. Trends Parasitol 32, 120-130.</p><p>Takeuchi, Y., Porter, C.D., Strahan, K.M., Preece, A.F., Gustafsson, K., Cosset, F.L., Weiss, R.A., and Collins, M.K. (1996). Sensitization of cells and retroviruses to human serum by (α 1-3) galactosyltransferase. Nature 379, 85-88.</p><p>Vonaesch, P., Anderson, M., and Sansonetti, P.J. (2018). Pathogens, microbiome and the host: emergence of the ecological Koch's postulates. FEMS microbiology reviews 42, 273-292.</p><p>Wang, X., Grus, W.E., and Zhang, J. (2006). Gene losses during human origins. PLoS Biol 4, e52.</p><p>Yilmaz, B., Portugal, S., Tran, T.M., Gozzelino, R., Ramos, S., Gomes, J., Regalado, A., Cowan, P.J., d'Apice, A.J., Chong, A.S., et al. (2014). Gut Microbiota Elicits a Protective Immune Response against Malaria Transmission. Cell 159, 1277-1289.</p></body></sub-article></article>